<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29641551</article-id><article-id pub-id-type="pmc">5895009</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0195041</article-id><article-id pub-id-type="publisher-id">PONE-D-17-34686</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Women's Health</subject><subj-group><subject>Maternal Health</subject><subj-group><subject>Pregnancy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Women's Health</subject><subj-group><subject>Obstetrics and Gynecology</subject><subj-group><subject>Pregnancy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Parathyroid Hormone</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin D</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin D</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Earth Sciences</subject><subj-group><subject>Geography</subject><subj-group><subject>Cartography</subject><subj-group><subject>Latitude</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Albumins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Disorders</subject><subj-group><subject>Diabetes Mellitus</subject><subj-group><subject>Gestational Diabetes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Metabolic Disorders</subject><subj-group><subject>Diabetes Mellitus</subject><subj-group><subject>Gestational Diabetes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine Disorders</subject><subj-group><subject>Diabetes Mellitus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Metabolic Disorders</subject><subj-group><subject>Diabetes Mellitus</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Glucose Tolerance Tests</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Alterations in the vitamin D endocrine system during pregnancy: A longitudinal study of 855 healthy Norwegian women</article-title><alt-title alt-title-type="running-head">Vitamin D endocrine system in pregnancy</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4151-393X</contrib-id><name><surname>Gustafsson</surname><given-names>Miriam K.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Romundstad</surname><given-names>P&#x000e5;l R.</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stafne</surname><given-names>Signe Nilssen</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Helvik</surname><given-names>Anne-Sofie</given-names></name><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Stunes</surname><given-names>Astrid Kamilla</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>M&#x000f8;rkved</surname><given-names>Siv</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Salvesen</surname><given-names>Kjell &#x000c5;smund</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thorsby</surname><given-names>Per Medb&#x000f8;e</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Syversen</surname><given-names>Unni</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff008"><sup>8</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Division of Mental Health Care, Trondheim University Hospital (St Olavs hospital), Trondheim, Norway</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Clinic of Clinical Services, Trondheim University Hospital (St Olavs hospital), Trondheim, Norway</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Trondheim University Hospital (St Olavs hospital), Trondheim, Norway</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Department of Obstetrics and Gynaecology, Trondheim University Hospital (St Olavs hospital), Trondheim, Norway</addr-line></aff><aff id="aff007"><label>7</label>
<addr-line>Hormone Laboratory, Department of Medical Biochemistry, Oslo University Hospital, Aker sykehus, Oslo, Norway</addr-line></aff><aff id="aff008"><label>8</label>
<addr-line>Department of Endocrinology, Trondheim University Hospital (St Olavs hospital), Trondheim, Norway</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Nguyen</surname><given-names>Tuan Van</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Garvan Institute of Medical Research, AUSTRALIA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>miriam.gustafsson@ntnu.no</email></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>4</issue><elocation-id>e0195041</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Gustafsson et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Gustafsson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0195041.pdf"/><abstract><p>To ensure optimal calcium accrual in the fetal skeleton, a substantial rise occurs in 1,25-dihydroxyvitamin D (1,25(OH)<sub>2</sub>D), but is dependent on sufficient 25-hydroxyvitamin (25(OH)D). Large longitudinal studies addressing free 25(OH)D and 1,25(OH)<sub>2</sub>D during pregnancy are scarce. We aimed to assess levels of and relationship between 25(OH)D, 1,25(OH)<sub>2</sub>D, vitamin D-binding protein (DBP), parathyroid hormone (PTH), and free 25(OH)D during pregnancy; determinants of vitamin D status; and association between vitamin D indices or PTH and pregnancy outcomes (gestational diabetes mellitus and birthweight). Altogether 855 pregnant Norwegian Caucasian women from Trondheim and Stavanger (latitude 63&#x000b0;N and 58&#x000b0;N) were recruited; 94 were lost to follow-up. The study was originally a randomized controlled trial (2007&#x02013;2009) with gestational diabetes as primary outcome. Data were collected in second and third trimester. In third trimester, 246 (34%) had vitamin D insufficiency and 52 (7%) deficiency (25(OH)D &#x0003c;50 and &#x0003c;30nmol/L, respectively). During wintertime in third trimester, 61 (47%) from Trondheim and 23 (51%) from Stavanger exhibited vitamin D insufficiency. PTH was elevated in 27 (3.7%). Estimate of change between trimesters was (95% CI): 25(OH)D -1.8 (-2.8 to -0.7) nmol/L, DBP 0.62 (0.57 to 0.66) &#x003bc;mol/L, calculated free 25(OH)D -1.7 (-2.0 to -1.4) pmol/L, PTH 0.81 (0.72 to 0.90) pmol/L, 1,25(OH)<sub>2</sub>D (sub-analysis) 31.4 (CI 24.7 to 38.2) pmol/L. A decrease in 1,25(OH)<sub>2</sub>D occurred in 45% of those with vitamin D deficiency, and they also exhibited lower levels than women with adequate vitamin D status. No association of vitamin D indices and PTH with pregnancy outcomes was observed. Women in Trondheim displayed lower 25(OH)D levels, despite minor latitudinal differences. Less than one-fifth adhered to the authorities&#x02019; vitamin D recommendations. These findings demonstrate that hypovitaminosis D is prevalent among pregnant women living in northern latitudes, especially during the dark season, and there is an unmet need to ensure adequate vitamin D intake.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).</institution></funding-source><principal-award-recipient><name><surname>M&#x000f8;rkved</surname><given-names>Siv</given-names></name></principal-award-recipient></award-group><funding-statement>The study was supported by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="5"/><page-count count="21"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Vitamin D (vitD) inadequacy among pregnant women is prevalent worldwide, and has been associated with adverse pregnancy outcomes [<xref rid="pone.0195041.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0195041.ref010" ref-type="bibr">10</xref>]. Developmental origins of disease have gained increasing attention, and maternal hypovitaminosis D during fetal life is one of the factors suggested to be of significance for future disease, including osteoporosis and cardiovascular disease [<xref rid="pone.0195041.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0195041.ref013" ref-type="bibr">13</xref>].</p><p>Ultraviolet-B (UVB) radiation of the skin is considered to be the major determinant of vitD levels [<xref rid="pone.0195041.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>]. However, due to latitude, cutaneous synthesis of vitD occurs less than six months of the year in the Nordic countries, and dietary content is also limited [<xref rid="pone.0195041.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>]. 25-hydroxyvitamin D (25(OH)D) is metabolized in the kidneys by 1-alpha-hydroxylase to the active form, 1,25-dihydroxyvitamin D (1,25(OH)<sub>2</sub>D) [<xref rid="pone.0195041.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref018" ref-type="bibr">18</xref>]. Through the vitamin D receptor, regulates 1,25(OH)<sub>2</sub>D hundreds of genes in a variety of body tissues [<xref rid="pone.0195041.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0195041.ref019" ref-type="bibr">19</xref>, <xref rid="pone.0195041.ref020" ref-type="bibr">20</xref>]. A major proportion of 25(OH)D and 1,25(OH)<sub>2</sub>D binds to vitamin D-binding protein (DBP) or albumin (&#x0003e;99%) [<xref rid="pone.0195041.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0195041.ref022" ref-type="bibr">22</xref>]. Free and bioavailable fractions seem to be more strongly correlated to the biological activity [<xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0195041.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pone.0195041.ref024" ref-type="bibr">24</xref>]. Serum levels of 25(OH)D are used for evaluation of vitD status [<xref rid="pone.0195041.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0195041.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0195041.ref021" ref-type="bibr">21</xref>]. The optimal levels of 25(OH)D and 1,25(OH)<sub>2</sub>D during pregnancy are, however, not settled, and recommendations concerning vitD intake are diverging [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0195041.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0195041.ref025" ref-type="bibr">25</xref>].</p><p>In pregnancy, the calcium requirement of the fetus results in profound changes in maternal calcium homeostasis [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>]. Whereas parathyroid hormone (PTH) plays a major role in calcium and bone metabolism in the non-pregnant state, vitD appears to be a prominent regulator during pregnancy [<xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. This is reflected in a two- to threefold rise in 1,25(OH)<sub>2</sub>D levels to increase intestinal calcium absorption, and ensure mineralization of the fetal skeleton [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. This rise is dependent on sufficient 25(OH)D [<xref rid="pone.0195041.ref028" ref-type="bibr">28</xref>]. The relationship between 25(OH)D and 1,25(OH)<sub>2</sub>D during pregnancy remains, however, unclear [<xref rid="pone.0195041.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>]. There are many determinants of 25(OH)D contributing to the diverse prevalence rates reported during pregnancy [<xref rid="pone.0195041.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0195041.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0195041.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0195041.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0195041.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0195041.ref030" ref-type="bibr">30</xref>]. A large variation in 1,25(OH)<sub>2</sub>D levels in third trimester has also been observed [<xref rid="pone.0195041.ref018" ref-type="bibr">18</xref>]. Larger longitudinal studies concerning 1,25(OH)<sub>2</sub>D, free and bio-available vitamin D in pregnancy are scarce [<xref rid="pone.0195041.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0195041.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>].</p><p>We aimed to assess 25(OH)D, 1,25(OH)<sub>2</sub>D and PTH levels and the relationship between these parameters among Caucasian women in the two final trimesters. DBP was analyzed for calculation of free and bioavailable 25(OH)D and free 1,25(OH)<sub>2</sub>D. Furthermore, we aimed to investigate determinants of vitD, including seasonal and latitudinal variation, and adherence to the recommendations on vitD and calcium intake. Finally, we wanted to explore the association of total and free 25(OH)D, 1,25(OH)<sub>2</sub>D and PTH levels with pregnancy outcomes (gestational diabetes mellitus (GDM) and birthweight).</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Study design and population</title><p>The current study included 855 pregnant Norwegian women from the cities of Trondheim (n = 660), latitude 63&#x000b0;N and Stavanger (n = 195), latitude 58&#x000b0;N (<xref ref-type="fig" rid="pone.0195041.g001">Fig 1</xref>). They participated originally in a randomized controlled trial (RCT), conducted between 2007 and 2009, aiming to investigate the antenatal health effects of an exercise program, and the primary outcome was gestational diabetes mellitus [<xref rid="pone.0195041.ref031" ref-type="bibr">31</xref>]. The present study was a secondary analysis of the RCT. Healthy Caucasian women, 18 years and older, with a singleton live fetus were included. Exclusion criteria were high-risk pregnancies and diseases that could hinder participation [<xref rid="pone.0195041.ref031" ref-type="bibr">31</xref>]. The two groups were homogenous at inclusion and after the intervention, and were merged in the current study.</p><fig id="pone.0195041.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.g001</object-id><label>Fig 1</label><caption><title>Flow diagram of the study population.</title><p>*Between 18 to 22 weeks of pregnancy. **Between 32 to 36 weeks of pregnancy. Abbreviations: DBP, Vitamin D-binding protein; PTH, parathyroid hormone.</p></caption><graphic xlink:href="pone.0195041.g001"/></fig><p>Serum 25(OH)D levels &#x0003c;50 nmol/L were classified as insufficiency and 25(OH)D levels &#x0003c;30 nmol/L as deficiency (VDD) according to the US Institute of Medicine (IOM) and Nordic Nutrition recommendations [<xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0195041.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0195041.ref032" ref-type="bibr">32</xref>]. The seasons were divided as follows: winter (December-February), spring (March-May), summer (June-August) and autumn (September-November). Gestational hypertension was defined as systolic blood pressure (BP) &#x0003e;140 mm Hg, diastolic BP &#x0003e;90 mm Hg, or both in women with no pregestational hypertension. The criteria for GDM were fasting glucose level in whole blood &#x02265;6.1 mmol/L, or plasma glucose &#x02265;7.0 mmol/L, or 2-hour glucose level &#x02265;7.8 mmol/L after oral glucose tolerance test in women with no pregestational diabetes mellitus [<xref rid="pone.0195041.ref031" ref-type="bibr">31</xref>].</p><p>The study was conducted in accordance with the ethical principles in the declaration of Helsinki, approved by the Regional Committee for Medical and Health Research Ethics (REK 4.2007.81) and registered in the ClinicalTrials.gov (NCT 00476567). Written informed consent was obtained from all participants.</p></sec><sec id="sec004"><title>Data collection</title><p>The participants were recruited consecutively, and clinical data and blood samples were collected in second and third trimester (pregnancy week 18&#x02013;22 and 32&#x02013;36) [<xref rid="pone.0195041.ref031" ref-type="bibr">31</xref>]. Questionnaires regarding sociodemographic variables, diet and supplements, childbirths, medical history, smoking behavior and physical activity were completed. A sub-analysis of circulating 1,25(OH)<sub>2</sub>D was performed in 250 women from Trondheim. To ensure that participants with both low and high levels of 25(OH)D were included in the subgroup analysis of 1,25(OH)<sub>2</sub>D, the serum levels of 25(OH)D in third trimester were divided into five categories: &#x02264;30 nmol/L, 25(OH)D &#x0003e;30 to &#x02264;50 nmol/L, 25(OH)D &#x0003e;50 to &#x02264;75 nmol/L, 25(OH)D &#x0003e;75 to &#x02264;100 nmol/L and 25(OH)D &#x0003e;100 nmol/L. From each category of 25(OH)D, 50 women were sampled for analysis of 1,25(OH)<sub>2</sub>D in second and third trimester. We have applied probability weights (the inverse of the probability of an observation being selected into the sample) in the statistical analyses of 1,25(OH)<sub>2</sub>D to produce estimates representative of the total Trondheim population [<xref rid="pone.0195041.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0195041.ref034" ref-type="bibr">34</xref>]</p></sec><sec id="sec005"><title>The Food Frequency Questionnaire</title><p>A self-administered optical mark readable Food Frequency Questionnaire (FFQ) containing around 180 food items was used to collect information about vitD and calcium intake [<xref rid="pone.0195041.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0195041.ref036" ref-type="bibr">36</xref>]. The serving size alternatives were specified in household units, and calculated in grams using a software developed at the Institute for Nutrition Research, University of Oslo [<xref rid="pone.0195041.ref035" ref-type="bibr">35</xref>]. The FFQ was established for dietary surveys in the general Norwegian population age 16 to 67 years, and has been validated [<xref rid="pone.0195041.ref035" ref-type="bibr">35</xref>, <xref rid="pone.0195041.ref037" ref-type="bibr">37</xref>].</p></sec><sec id="sec006"><title>Serum analyses</title><p>Blood samples were collected after fasting, and the sera were stored at -80&#x000b0;C. The following analyses were conducted at Trondheim University Hospital: 25(OH)D and PTH by electrochemiluminescence immunoassay (ECLIA), calcium by a colorimetric method, and magnesium, phosphate, albumin and creatinine by photometric methods. All assays were delivered by Roche Diagnostics Ltd., Switzerland. Total calcium was corrected for the albumin concentration [<xref rid="pone.0195041.ref038" ref-type="bibr">38</xref>]. DBP and 1,25(OH)<sub>2</sub>D were analyzed at the Hormone Laboratory, Oslo University Hospital; DBP by an in-house competitive radioimmunoassay with GC-globulin (Sigma-Aldrich Corp, St. Louis, MO, USA) and polyclonal anti-GC-globulin antibodies (DakoCytomation, Glostrup, Denmark), and 1,25(OH)<sub>2</sub>D by an enzyme immunoassay (IDS Nordic A/S immunodiagnosticsystems) [<xref rid="pone.0195041.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0195041.ref040" ref-type="bibr">40</xref>]. Reference range, limit of detection and coefficient of analytical variation (CV) for the different analyses are presented in <xref ref-type="supplementary-material" rid="pone.0195041.s001">S1 Table</xref>.</p></sec><sec id="sec007"><title>Calculation of free and bioavailable 25(OH)D and free 1,25(OH)<sub>2</sub>D</title><p>We compared two methods reported by Vermeulen et al. and Bikle et al. for calculation of free 25(OH)D, and the estimates were similar (difference of ~1%) [<xref rid="pone.0195041.ref041" ref-type="bibr">41</xref>&#x02013;<xref rid="pone.0195041.ref043" ref-type="bibr">43</xref>]. Free 25(OH)D and 1,25(OH)<sub>2</sub>D are presented according to Bikle et al. [<xref rid="pone.0195041.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0195041.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0195041.ref044" ref-type="bibr">44</xref>]:
<disp-formula id="pone.0195041.e001"><alternatives><graphic xlink:href="pone.0195041.e001.jpg" id="pone.0195041.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo>]</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mo>+</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>]</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="normal">D</mml:mi><mml:mi mathvariant="normal">B</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math></alternatives></disp-formula></p><p>D<sub>free</sub> is the calculated free levels of 25(OH)D or 1,25(OH)<sub>2</sub>D. D<sub>total</sub> is the total serum levels of 25(OH)D or 1,25(OH)<sub>2</sub>D. Albumin-bound 25(OH)D (D<sub>alb</sub>) was calculated as follows [<xref rid="pone.0195041.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0195041.ref042" ref-type="bibr">42</xref>]:
<disp-formula id="pone.0195041.e002"><alternatives><graphic xlink:href="pone.0195041.e002.jpg" id="pone.0195041.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:msub><mml:mrow><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mn>25</mml:mn><mml:mo>(</mml:mo><mml:mrow><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mi mathvariant="normal">D</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mo>[</mml:mo><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo>]</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:math></alternatives></disp-formula></p><p>The binding constant was 6 x10<sup>5</sup> M<sup>-1</sup> between 25(OH)D and albumin, and 5.4 x 10<sup>4</sup> M<sup>-1</sup> between 1,25(OH)<sub>2</sub>D and albumin. The binding constant was 7 x 10<sup>8</sup> M<sup>-1</sup> between 25(OH)D and DBP, and 3.7 x 10<sup>7</sup> M<sup>-1</sup> between 1,25(OH)<sub>2</sub>D and DBP [<xref rid="pone.0195041.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0195041.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0195041.ref044" ref-type="bibr">44</xref>]. Bioavailable 25(OH)D was calculated as the sum of albumin-bound and free 25(OH)D [<xref rid="pone.0195041.ref042" ref-type="bibr">42</xref>]. The percentage of free 25(OH)D was estimated as [<xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>]:
<disp-formula id="pone.0195041.e003"><alternatives><graphic xlink:href="pone.0195041.e003.jpg" id="pone.0195041.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mspace width="0.25em"/><mml:mn>25</mml:mn><mml:mo>(</mml:mo><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">H</mml:mi><mml:mo>)</mml:mo><mml:mi mathvariant="normal">D</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mspace width="0.25em"/><mml:mn>25</mml:mn><mml:mo>(</mml:mo><mml:mi mathvariant="normal">O</mml:mi><mml:mi mathvariant="normal">H</mml:mi><mml:mo>)</mml:mo><mml:mi mathvariant="normal">D</mml:mi></mml:mrow></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">x</mml:mi><mml:mspace width="0.25em"/><mml:mn>100</mml:mn></mml:math></alternatives></disp-formula></p></sec><sec id="sec008"><title>Statistical analyses</title><p>SPSS statistics Version 22.0 (Armonk, NY: IBM Corp) and Stata version 13 (StataCorp LP, College Station, TX, USA) were used for the statistical analyses. In general data are presented as the arithmetic mean with standard deviation (SD) or 95% confidence intervals (CI).</p><p>A mixed model with fixed effects (streg with fe option) was used in Stata to study within-subject variations of vitamin D and related measures from second to third trimester [<xref rid="pone.0195041.ref045" ref-type="bibr">45</xref>]. The model included a random intercept. To account for the considerable variation in exposure to sunlight over the year and increase the precision, we adjusted for season. Model-based serum levels in second and third trimester were estimated by using the postestimation command lincom (linear combinations of estimators). Each season was given a weight of 0.25 and this approach gave an estimate covering each season with similar weights.</p><p>To evaluate differences between study sites by season, we used multivariable linear regression and did separate analyses for second and third trimester. In these analyses, we adjusted for season, age, pre-pregnancy BMI, parity and pre-pregnancy physical activity. When we performed analyses for the third trimester, we also adjusted for group randomization (from the in the original RCT) to take potential treatments effects into account. In the model, we allowed for interaction between study site and season, and used likelihood ratio test to assess possible interactions. In additional analyses we adjusted for vitamin D supplementation and education.</p><p>The model-based serum levels in Trondheim and Stavanger and the seasonal serum levels at both study sites were estimated using the postestimation command lincom. In the model, each season was given a weight of 0.25. Furthermore, pre-pregnancy physical activity was given a weight of 0.71 (based on the proportion of women that were exercising regularly before pregnancy), and parity 0.43 (based on the proportion of women with one or more children). Continuous variables (pre-pregnancy BMI and age) were mean-centered.</p><p>Linear and logistic regression analyses were used to estimate the potential association between serum levels of total 25(OH)D, calculated free 25(OH)D, 1,25(OH)<sub>2</sub>D and PTH levels in second trimester and pregnancy outcomes (GDM and birthweight (BW)). The same analyses were also performed in third trimester. In the multivariable regression models, we adjusted for study site, season, age, pre-pregnancy BMI, parity and pre-pregnancy physical activity. In additional analyses, we also adjusted for education, and intake of vitamin D, calcium and fish.</p><p>To assess the association between total 25(OH)D and 1,25(OH)<sub>2</sub>D we used simple linear regression. In all analyses involving 1,25(OH)<sub>2</sub>D, we used the pweight function in Stata to account for the sampling scheme (the inverse of the probability of an observation being selected into the sample). In this study we did not make any adjustment for multiple testing.</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Population</title><p>The participants from Trondheim and Stavanger were homogeneous in terms of baseline characteristics (<xref ref-type="table" rid="pone.0195041.t001">Table 1</xref>). Prenatally, 17 (2.0%) were underweight (BMI &#x0003c;18.5), 645 (76.7%) had normal weight (BMI 18.5&#x02013;24.99), 141 (16.8%) were overweight (BMI 25&#x02013;29.99) and 38 (4.5%) were obese (BMI &#x02265;30) according to the classification of the World Health Organization [<xref rid="pone.0195041.ref046" ref-type="bibr">46</xref>]. No one had class III obesity with BMI &#x02265;40. A very slight increase in supplemental vitD intake (0.04 &#x003bc;g) was observed between second and third trimester. A total of 18% followed the recommendations of a daily intake of 10 &#x003bc;g vitamin D supplement in the second and third trimester (Tables <xref ref-type="table" rid="pone.0195041.t001">1</xref> and <xref ref-type="table" rid="pone.0195041.t002">2</xref>). In third trimester, 18 women had gestational hypertension and 43 had GDM. The mean BW was 3,519 &#x000b1; 540 grams (<xref ref-type="supplementary-material" rid="pone.0195041.s002">S2 Table</xref>). At the second sample collection, 58 women from Trondheim and 36 from Stavanger were lost to follow-up (<xref ref-type="fig" rid="pone.0195041.g001">Fig 1</xref>). The characteristics did not differ from the original population, although a lower proportion exercised regularly pre-pregnancy (59% vs. 71%). Serum analyses from two women in second trimester and two in third trimester could not be completed in the sub-analysis (n = 250) of 1,25(OH)<sub>2</sub>D.</p><table-wrap id="pone.0195041.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.t001</object-id><label>Table 1</label><caption><title>Baseline demographic and clinical characteristics of the study population<xref ref-type="table-fn" rid="t001fn002"><sup>&#x02020;</sup></xref>.</title></caption><alternatives><graphic id="pone.0195041.t001g" xlink:href="pone.0195041.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Maternal characteristics</th><th align="left" rowspan="1" colspan="1">Total<break/>(<italic>n</italic> = 855)</th><th align="justify" rowspan="1" colspan="1">Trondheim 63&#x000b0;N<break/>(<italic>n</italic> = 660)</th><th align="left" rowspan="1" colspan="1">Stavanger 58&#x000b0;N<break/>(<italic>n</italic> = 195)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="justify" rowspan="1" colspan="1">30.5 &#x000b1; 4.3</td><td align="left" rowspan="1" colspan="1">30.4 &#x000b1; 4.3</td><td align="left" rowspan="1" colspan="1">30.6 &#x000b1; 4.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Gestational length at inclusion (weeks)<xref ref-type="table-fn" rid="t001fn005">*</xref></td><td align="justify" rowspan="1" colspan="1">20.0 &#x000b1; 1.7</td><td align="left" rowspan="1" colspan="1">20.0 &#x000b1; 1.7</td><td align="left" rowspan="1" colspan="1">20.7 &#x000b1; 1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Marital status <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn006">**</xref></td><td align="justify" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Married/cohabitant</td><td align="justify" rowspan="1" colspan="1">834 (97.7)</td><td align="left" rowspan="1" colspan="1">645 (97.9)</td><td align="left" rowspan="1" colspan="1">189 (96.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Single</td><td align="justify" rowspan="1" colspan="1">20 (2.3)</td><td align="left" rowspan="1" colspan="1">14 (2.1)</td><td align="left" rowspan="1" colspan="1">6 (3.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Education level <italic>n</italic> (%)</td><td align="justify" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Elementary school</td><td align="justify" rowspan="1" colspan="1">5 (0.6)</td><td align="left" rowspan="1" colspan="1">3 (0.5)</td><td align="left" rowspan="1" colspan="1">2 (1.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;High School</td><td align="justify" rowspan="1" colspan="1">90 (10.5)</td><td align="left" rowspan="1" colspan="1">64 (9.7)</td><td align="left" rowspan="1" colspan="1">26 (13.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;University</td><td align="justify" rowspan="1" colspan="1">760 (88.9)</td><td align="left" rowspan="1" colspan="1">593 (89.8)</td><td align="left" rowspan="1" colspan="1">167 (85.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Paid work or self-employed <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn006">**</xref></td><td align="justify" rowspan="1" colspan="1">793 (92.9)</td><td align="left" rowspan="1" colspan="1">614 (93.2)</td><td align="left" rowspan="1" colspan="1">184 (94.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Parity <italic>n</italic> (%)</td><td align="justify" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;0</td><td align="justify" rowspan="1" colspan="1">486 (56.8)</td><td align="left" rowspan="1" colspan="1">374 (56.7)</td><td align="left" rowspan="1" colspan="1">112 (57.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;1</td><td align="justify" rowspan="1" colspan="1">254 (29.7)</td><td align="left" rowspan="1" colspan="1">199 (30.2)</td><td align="left" rowspan="1" colspan="1">55 (28.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;2</td><td align="justify" rowspan="1" colspan="1">90 (10.5)</td><td align="left" rowspan="1" colspan="1">68 (10.3)</td><td align="left" rowspan="1" colspan="1">22 (11.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;3+</td><td align="justify" rowspan="1" colspan="1">25 (2.9)</td><td align="left" rowspan="1" colspan="1">19 (2.9)</td><td align="left" rowspan="1" colspan="1">6 (3.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn006">**</xref></td><td align="justify" rowspan="1" colspan="1">9 (1.1)</td><td align="left" rowspan="1" colspan="1">5 (0.8)</td><td align="left" rowspan="1" colspan="1">4 (2.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Inclusion body mass index (kg/m<sup>2</sup>)<xref ref-type="table-fn" rid="t001fn006">**</xref></td><td align="justify" rowspan="1" colspan="1">24.8 &#x000b1; 3.2</td><td align="left" rowspan="1" colspan="1">24.9 &#x000b1; 3.3</td><td align="left" rowspan="1" colspan="1">24.7 &#x000b1; 3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood pressure (mm Hg)</td><td align="justify" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Systolic</td><td align="justify" rowspan="1" colspan="1">108.9 &#x000b1; 8.6</td><td align="left" rowspan="1" colspan="1">108.9 &#x000b1; 8.6</td><td align="left" rowspan="1" colspan="1">108.9 &#x000b1; 8.5</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Diastolic</td><td align="justify" rowspan="1" colspan="1">68.7 &#x000b1; 7.8</td><td align="left" rowspan="1" colspan="1">69.4 &#x000b1; 7.7</td><td align="left" rowspan="1" colspan="1">66.5 &#x000b1; 7.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Gestational hypertension <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn003"><sup>&#x02020;&#x02020;</sup></xref></td><td align="justify" rowspan="1" colspan="1">9 (1.1)</td><td align="left" rowspan="1" colspan="1">8 (1.2)</td><td align="left" rowspan="1" colspan="1">1 (0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gestational diabetes <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn007">***</xref>
<xref ref-type="table-fn" rid="t001fn004"><sup>&#x02020;&#x02020;&#x02020;</sup></xref></td><td align="justify" rowspan="1" colspan="1">5 (0.6)</td><td align="left" rowspan="1" colspan="1">5 (0.8)</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily total vitD intake (&#x003bc;g)</td><td align="justify" rowspan="1" colspan="1">10.4 &#x000b1; 7.0</td><td align="left" rowspan="1" colspan="1">10.6 &#x000b1; 7.1</td><td align="left" rowspan="1" colspan="1">9.8 &#x000b1; 6.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily total vitD intake &#x0003c;10 &#x003bc;g <italic>n</italic> (%)</td><td align="justify" rowspan="1" colspan="1">507 (59.3)</td><td align="left" rowspan="1" colspan="1">383 (58.0)</td><td align="left" rowspan="1" colspan="1">124 (63.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily vitD from supplements (&#x003bc;g)<xref ref-type="table-fn" rid="t001fn008">****</xref></td><td align="justify" rowspan="1" colspan="1">5.5 &#x000b1; 6.5</td><td align="left" rowspan="1" colspan="1">5.7 &#x000b1; 6.6</td><td align="left" rowspan="1" colspan="1">5.0 &#x000b1; 6.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of &#x02265;10 &#x003bc;g vitD from supplements <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn008">****</xref></td><td align="justify" rowspan="1" colspan="1">157 (18.4)</td><td align="left" rowspan="1" colspan="1">124 (18.8)</td><td align="left" rowspan="1" colspan="1">33 (17.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of fish (g)<xref ref-type="table-fn" rid="t001fn008">****</xref></td><td align="justify" rowspan="1" colspan="1">54.8 &#x000b1; 38.3</td><td align="left" rowspan="1" colspan="1">54.4 &#x000b1; 38.5</td><td align="left" rowspan="1" colspan="1">56.0 &#x000b1; 37.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Intake of fish &#x0003c;300 g/week <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn008">****</xref></td><td align="justify" rowspan="1" colspan="1">383 (45.0)</td><td align="left" rowspan="1" colspan="1">299 (45.4)</td><td align="left" rowspan="1" colspan="1">84 (43.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of calcium (mg)<xref ref-type="table-fn" rid="t001fn008">****</xref></td><td align="justify" rowspan="1" colspan="1">974.8 &#x000b1; 374.1</td><td align="left" rowspan="1" colspan="1">976.9 &#x000b1; 373.3</td><td align="left" rowspan="1" colspan="1">967.7 &#x000b1; 377.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily calcium intake &#x0003c;900 mg <italic>n</italic> (%)<xref ref-type="table-fn" rid="t001fn008">****</xref></td><td align="justify" rowspan="1" colspan="1">401 (47.1)</td><td align="left" rowspan="1" colspan="1">304 (46.2)</td><td align="left" rowspan="1" colspan="1">97 (50.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercised regularly pre-pregnancy <italic>n</italic> (%)</td><td align="justify" rowspan="1" colspan="1">610 (71.3)</td><td align="left" rowspan="1" colspan="1">476 (72.1)</td><td align="left" rowspan="1" colspan="1">134 (68.7)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Continuous variables are given as means &#x000b1; standard deviations (SD), and categorical variables are given as (<italic>n</italic>) with percentages (%). The Norwegian authorities&#x02019; recommendations for pregnant women are a daily vitD supplement intake of 10 &#x003bc;g, a weekly intake of 300&#x02013;450 g fish and additionally 900 mg calcium per day.</p></fn><fn id="t001fn002"><p><sup>&#x02020;</sup>The inclusion appointment was between 18&#x02013;22 weeks of pregnancy.</p></fn><fn id="t001fn003"><p><sup>&#x02020;&#x02020;</sup>Gestational hypertension is defined as systolic blood pressure &#x0003e;140 mm Hg, diastolic blood pressure &#x0003e;90 mm Hg, or both in women with no pregestational hypertension.</p></fn><fn id="t001fn004"><p><sup>&#x02020;&#x02020;&#x02020;</sup>The criteria for gestational diabetes were fasting glucose level in whole blood &#x02265;6.1 mmol/L, or plasma glucose &#x02265;7.0 mmol/L, or 2-hour glucose level &#x02265;7.8 mmol/L after oral glucose tolerance test in women with no pregestational diabetes.</p></fn><fn id="t001fn005"><p>*Ten women from Trondheim and two from Stavanger are missing.</p></fn><fn id="t001fn006"><p>**One woman from Trondheim is missing.</p></fn><fn id="t001fn007"><p>***14 women from Trondheim and five women from Stavanger are missing.</p></fn><fn id="t001fn008"><p>****One woman from Stavanger and two women from Trondheim and are missing.</p></fn><fn id="t001fn009"><p>Abbreviation: vitD, vitamin D.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone.0195041.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.t002</object-id><label>Table 2</label><caption><title>Vitamin D, calcium and fish intake in third trimester<xref ref-type="table-fn" rid="t002fn002">*</xref>.</title></caption><alternatives><graphic id="pone.0195041.t002g" xlink:href="pone.0195041.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Total population<break/>(<italic>n</italic> = 761)</th><th align="center" rowspan="1" colspan="1">Trondheim 63&#x000b0;N<break/>(<italic>n</italic> = 602)</th><th align="center" rowspan="1" colspan="1">Stavanger 58&#x000b0;N<break/>(<italic>n</italic> = 159)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Daily total vitD intake (&#x003bc;g)</td><td align="center" rowspan="1" colspan="1">10.3 &#x000b1; 7.3</td><td align="center" rowspan="1" colspan="1">10.3 &#x000b1; 7.4</td><td align="center" rowspan="1" colspan="1">10.4 &#x000b1; 6.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily total vitD intake &#x0003c;10 &#x003bc;g <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">463 (60.8)</td><td align="center" rowspan="1" colspan="1">366 (60.8)</td><td align="center" rowspan="1" colspan="1">97 (61.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily vitD from supplements (&#x003bc;g)<xref ref-type="table-fn" rid="t002fn003">**</xref></td><td align="center" rowspan="1" colspan="1">5.6 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">5.6 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">5.9 &#x000b1; 6.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of &#x02265;10 &#x003bc;g vitD from supplements <italic>n</italic> (%)<xref ref-type="table-fn" rid="t002fn003">**</xref></td><td align="center" rowspan="1" colspan="1">139 (18.3)</td><td align="center" rowspan="1" colspan="1">108 (18.0)</td><td align="center" rowspan="1" colspan="1">31 (19.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of fish (g)<xref ref-type="table-fn" rid="t002fn003">**</xref></td><td align="center" rowspan="1" colspan="1">49.1 &#x000b1; 32.3</td><td align="center" rowspan="1" colspan="1">49.5 &#x000b1; 32.6</td><td align="center" rowspan="1" colspan="1">47.5 &#x000b1; 30.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Intake of fish &#x0003c;300 g/week <italic>n</italic> (%)<xref ref-type="table-fn" rid="t002fn003">**</xref></td><td align="center" rowspan="1" colspan="1">390 (51.5)</td><td align="center" rowspan="1" colspan="1">306 (51.1)</td><td align="center" rowspan="1" colspan="1">84 (52.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of calcium (mg)<xref ref-type="table-fn" rid="t002fn003">**</xref></td><td align="center" rowspan="1" colspan="1">960.6 &#x000b1; 344.5</td><td align="center" rowspan="1" colspan="1">962.7 &#x000b1; 352.1</td><td align="center" rowspan="1" colspan="1">952.9 &#x000b1; 315.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Daily intake of calcium &#x0003c;900 mg <italic>n</italic> (%) <xref ref-type="table-fn" rid="t002fn003">**</xref></td><td align="center" rowspan="1" colspan="1">348 (45.9)</td><td align="center" rowspan="1" colspan="1">276 (46.1)</td><td align="center" rowspan="1" colspan="1">72 (45.3)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Continuous variables are given as means &#x000b1; standard deviations (SD) and categorical variables are given as numbers (<italic>n</italic>) with percentages (%). The Norwegian authorities&#x02019; recommendations for pregnant women are a daily vitD supplement intake of 10 &#x003bc;g, a weekly intake of 300&#x02013;450 g fish and additionally 900 mg calcium per day.</p></fn><fn id="t002fn002"><p>*The appointment was between 32&#x02013;36 weeks of pregnancy.</p></fn><fn id="t002fn003"><p><sup><bold>**</bold></sup>Three from Trondheim are missing.</p></fn><fn id="t002fn004"><p>Abbreviation: vitD, vitamin D.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec011"><title>Crude serum values in pregnancy</title><p>In <xref ref-type="table" rid="pone.0195041.t003">Table 3</xref> crude serum values of 25(OH)D, calculated free 25(OH)D, albumin-bound 25(OH)D, bioavailable 25(OH)D, PTH, calcium, corrected calcium, magnesium, phosphate, albumin and DBP in second and third trimester are presented. The mean crude 25(OH)D levels in second and third trimester were 66.1 &#x000b1; 24.8 and 64.3 &#x000b1; 27.1 nmol/L, respectively. In second trimester, 232 (27%) had vitD insufficiency and 40 (5%) deficiency. In third trimester, the corresponding numbers were 246 (34%) and 52 (7%). Mean PTH concentrations were 2.8 &#x000b1; 1.09 and 3.6 &#x000b1; 1.51 pmol/L, respectively, in second and third trimester. In third trimester, 27 (3.7%) had PTH levels above the upper reference limit (6.9 pmol/L). Of these, 56% had vitD insufficiency or VDD. None of those with elevated PTH had 25(OH)D levels &#x0003e;74 nmol/L. PTH elevation was more frequent (82%) in the autumn, winter and spring. Corrected calcium, magnesium, phosphate and creatinine levels were within reference range. In a sub-analysis, 1,25(OH)<sub>2</sub>D levels ranged from 97&#x02013;408 and 105&#x02013;408 pmol/L, in second and third trimester. Crude mean 1,25(OH)<sub>2</sub>D levels were 199.1 (CI 192.9 to 205.2) and 229.1 (CI 220.9 to 237.3) pmol/L in second and third trimester, respectively. Calculated free 1,25(OH)<sub>2</sub>D was 833.0 (CI 806.2 to 859.8) fmol/L in second trimester and 876.7 (CI 845.9 to 907.5) fmol/L third trimester.</p><table-wrap id="pone.0195041.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.t003</object-id><label>Table 3</label><caption><title>Crude serum values in second<xref ref-type="table-fn" rid="t003fn002">*</xref> and third<xref ref-type="table-fn" rid="t003fn003">**</xref> trimester.</title></caption><alternatives><graphic id="pone.0195041.t003g" xlink:href="pone.0195041.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Serum measures</th><th align="center" rowspan="1" colspan="1">Serum levels<break/>Total</th><th align="center" rowspan="1" colspan="1">Serum levels<break/>Trondheim 63&#x000b0;N</th><th align="center" rowspan="1" colspan="1">Serum levels<break/>Stavanger 58&#x000b0;N</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Second trimester</bold></td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 855)<xref ref-type="table-fn" rid="t003fn004"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 660)<xref ref-type="table-fn" rid="t003fn004"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">(<italic>n</italic> = 195)</td></tr><tr><td align="left" rowspan="1" colspan="1">25OH)D (nmol/L)</td><td align="center" rowspan="1" colspan="1">66.1 &#x000b1; 24.8</td><td align="center" rowspan="1" colspan="1">64.8 &#x000b1; 24.2</td><td align="center" rowspan="1" colspan="1">70.4 &#x000b1; 26.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Calculated free 25(OH)D (pmol/L)<xref ref-type="table-fn" rid="t003fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">15.3 &#x000b1; 5.9</td><td align="center" rowspan="1" colspan="1">15.1 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">15.9 &#x000b1; 6.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin-bound 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t003fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">5.06 &#x000b1; 1.98</td><td align="center" rowspan="1" colspan="1">5.01 &#x000b1; 1.96</td><td align="center" rowspan="1" colspan="1">5.23 &#x000b1; 2.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Bioavailable 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t003fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">5.08 &#x000b1; 1.99</td><td align="center" rowspan="1" colspan="1">5.03 &#x000b1; 1.96</td><td align="center" rowspan="1" colspan="1">5.25 &#x000b1; 2.08</td></tr><tr><td align="left" rowspan="1" colspan="1">PTH (pmol/L)</td><td align="center" rowspan="1" colspan="1">2.77 &#x000b1; 1.09</td><td align="center" rowspan="1" colspan="1">2.82 &#x000b1; 1.10</td><td align="center" rowspan="1" colspan="1">2.61 &#x000b1; 1.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium (mmol/L)</td><td align="center" rowspan="1" colspan="1">2.27 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.27 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.27 &#x000b1; 0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Corrected calcium (mmol/L)</td><td align="center" rowspan="1" colspan="1">2.34 &#x000b1; 0.06</td><td align="center" rowspan="1" colspan="1">2.34 &#x000b1; 0.06</td><td align="center" rowspan="1" colspan="1">2.34 &#x000b1; 0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">Magnesium (mmol/L)<xref ref-type="table-fn" rid="t003fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">0.75 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">0.75 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">0.73 &#x000b1; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphate (mmol/L)</td><td align="center" rowspan="1" colspan="1">1.19 &#x000b1; 0.12</td><td align="center" rowspan="1" colspan="1">1.20 &#x000b1; 0.13</td><td align="center" rowspan="1" colspan="1">1.18 &#x000b1; 0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/L)</td><td align="center" rowspan="1" colspan="1">36.7 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">36.7 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">36.5 &#x000b1; 1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (&#x003bc;mol/L)<xref ref-type="table-fn" rid="t003fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">5.8 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">5.7 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">6.0 &#x000b1; 0.8</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Third trimester</bold></td><td align="center" rowspan="1" colspan="1">(n = 761)</td><td align="center" rowspan="1" colspan="1">(n = 603)</td><td align="center" rowspan="1" colspan="1">(n = 158)</td></tr><tr><td align="left" rowspan="1" colspan="1">25OH)D (nmol/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">64.3 &#x000b1; 27.1</td><td align="center" rowspan="1" colspan="1">63.6 &#x000b1; 26.4</td><td align="center" rowspan="1" colspan="1">66.9 &#x000b1; 29.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Calculated free 25(OH)D (pmol/L)<xref ref-type="table-fn" rid="t003fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">13.6 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">13.6 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">13.7 &#x000b1; 6.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin-bound 25(OH)D<break/> (nmol/L)<xref ref-type="table-fn" rid="t003fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">4.14 &#x000b1; 1.77</td><td align="center" rowspan="1" colspan="1">4.14 &#x000b1; 1.76</td><td align="center" rowspan="1" colspan="1">4.13 &#x000b1; 1.81</td></tr><tr><td align="left" rowspan="1" colspan="1">Bioavailable 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t003fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">4.15 &#x000b1; 1.77</td><td align="center" rowspan="1" colspan="1">4.15 &#x000b1; 1.77</td><td align="center" rowspan="1" colspan="1">4.15 &#x000b1; 1.82</td></tr><tr><td align="left" rowspan="1" colspan="1">PTH (pmol/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">3.61 &#x000b1; 1.51</td><td align="center" rowspan="1" colspan="1">3.68 &#x000b1; 1.53</td><td align="center" rowspan="1" colspan="1">3.32 &#x000b1; 1.40</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium (mmol/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">2.25 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.25 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.25 &#x000b1; 0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Corrected calcium (mmol/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">2.37 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.37 &#x000b1; 0.07</td><td align="center" rowspan="1" colspan="1">2.38 &#x000b1; 0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Magnesium (mmol/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">0.73 &#x000b1; 0.05</td><td align="center" rowspan="1" colspan="1">0.74 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">0.71 &#x000b1; 0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphate (mmol/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">1.17 &#x000b1; 0.14</td><td align="center" rowspan="1" colspan="1">1.17 &#x000b1; 0.14</td><td align="center" rowspan="1" colspan="1">1.18 &#x000b1; 0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/L)<xref ref-type="table-fn" rid="t003fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">33.8 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">33.8 &#x000b1; 1.9</td><td align="center" rowspan="1" colspan="1">33.6 &#x000b1; 1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (&#x003bc;mol/L)<xref ref-type="table-fn" rid="t003fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">6.4 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">6.3 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">6.6 &#x000b1; 0.8</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Serum levels are presented as means &#x000b1; standard deviations (SD).</p></fn><fn id="t003fn002"><p>*The blood samples were collected between 18&#x02013;22 weeks of pregnancy.</p></fn><fn id="t003fn003"><p>**The blood samples were collected between 32&#x02013;36 weeks of pregnancy.</p></fn><fn id="t003fn004"><p><sup>a</sup>One woman from Trondheim is missing.</p></fn><fn id="t003fn005"><p><sup>b</sup>One women from Stavanger is missing.</p></fn><fn id="t003fn006"><p><sup>c</sup>23 women from Trondheim and 14 women from Stavanger are missing.</p></fn><fn id="t003fn007"><p><sup>d</sup>24 women from Trondheim and 14 women from Stavanger are missing.</p></fn><fn id="t003fn008"><p>Abbreviations: PTH, parathyroid hormone; DBP, Vitamin D-binding protein.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec012"><title>Changes in indices of vitamin D and other serum parameters between second and third trimester</title><p>A slight decrease occurred in total 25(OH)D between second and third trimester (<xref ref-type="table" rid="pone.0195041.t004">Table 4</xref>). Increasing or indifferent levels were observed in 314 (43%), whereas 410 (57%) experienced a decline. 1,25(OH)<sub>2</sub>D, PTH and DBP levels were increasing, whereas calcium, magnesium, phosphate and albumin decreased (<xref ref-type="table" rid="pone.0195041.t004">Table 4</xref>). A decline was observed in free 25(OH)D, the percentage of free 25(OH)D (0.023% versus 0.021%, p &#x0003c;0.0001) and bioavailable 25(OH)D. Corrected calcium was increasing (<xref ref-type="table" rid="pone.0195041.t004">Table 4</xref>).</p><table-wrap id="pone.0195041.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.t004</object-id><label>Table 4</label><caption><title>Adjusted serum values in second and third trimester, and estimates of change between trimesters.</title></caption><alternatives><graphic id="pone.0195041.t004g" xlink:href="pone.0195041.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Serum measures</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Serum values in second trimester<xref ref-type="table-fn" rid="t004fn001">*</xref></th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Serum values in third trimester<xref ref-type="table-fn" rid="t004fn002">**</xref></th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Estimates of change between<break/>second and third trimester<break/>(95% CI)</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t004fn003">***</xref></th></tr></thead><tbody><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">25(OH)D (nmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">66.4</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">64.6</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-1.8 (-2.8 to -0.7)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Calculated free 25(OH)D (pmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">15.4</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">13.7</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-1.7 (-2.0 to -1.4)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Albumin-bound 25(OH)D (nmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">5.09</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">4.15</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.94 (-1.03 to -0.84)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Bioavailable 25(OH)D (nmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">5.10</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">4.17</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.93 (-1.03 to -0.85)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">PTH (pmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">2.78</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">3.59</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.81 (0.72 to 0.90)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Calcium (mmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">2.269</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">2.247</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.023 (-0.027 to -0.018)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Corrected Calcium (mmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">2.337</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">2.372</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.035 (0.031 to 0.039)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Magnesium (mmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.747</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.730</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.017 (-0.020 to -0.015)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Phosphate (mmol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1.195</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1.172</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-0.022 (-0.032 to -0.013)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Albumin (g/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">36.7</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">33.7</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-2.9 (-3.1 to -2.8)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">DBP (&#x003bc;mol/L)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">5.77</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">6.39</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">0.62 (0.57 to 0.66)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>*The blood samples in second trimester were collected between 18&#x02013;22 weeks of pregnancy.</p></fn><fn id="t004fn002"><p><bold>**</bold>The blood samples in third trimester were collected between 32&#x02013;36 weeks of pregnancy.</p></fn><fn id="t004fn003"><p>*** A mixed model with fixed effects (streg with fe option) was used in Stata. The model included a random intercept. We adjusted for season. The model-based levels in second and third trimester were estimated by using the postestimation command lincom (linear combinations of estimators).</p></fn><fn id="t004fn004"><p>Abbreviations: CI, confidence interval; PTH, parathyroid hormone; DBP, vitamin D- binding protein.</p></fn></table-wrap-foot></table-wrap><p>Among the 250 women in the sub-analysis, the seasonally adjusted 1,25(OH)<sub>2</sub>D concentration increased from 198.9 (CI 195.6 to 202.2) pmol/L to 230.3 (CI 226.9 to 233.8) pmol/L) (change = 31.4 (CI 24.7 to 38.2) pmol/L, p &#x0003c;0.0001). A decline in 1,25(OH)<sub>2</sub>D concentration was observed in 26% (crude data). Among those with 25(OH)D &#x0003c;30 nmol/L and 25(OH)D &#x0003e;75 nmol/L in the third trimester, 45% and 17%, respectively experienced a decline in 1,25(OH)<sub>2</sub>D between the trimesters. Five percent of those women with falling 1,25(OH)<sub>2</sub>D had PTH elevation above the reference range, and all subjects in this group showed 25(OH)D levels &#x0003c;34 nmol/L (third trimester). In both second and third trimester, women with vitamin D insufficiency and deficiency displayed lower 1,25(OH)<sub>2</sub>D levels than those with adequate vitD status. In a linear regression model, each 1 nmol/L increment in the 25(OH)D concentration increased the levels of 1,25(OH)<sub>2</sub>D by 0.74 pmol/L (CI 0.53 to 0.96 pmol/L, p &#x0003c;0.0001), and by 0.92 pmol/L (CI 0.69 to 1.14 pmol/L, p &#x0003c;0.0001) in second and third trimester, respectively. Season adjusted calculated free 1,25(OH)<sub>2</sub>D increased from 832.1 (CI 818.9 to 845.1) fmol/L in second trimester to 881.7 (CI 868.3 to 895.1) fmol/L in third trimester (change = 49.7 (CI 23.2 to 76.2) fmol/L, p &#x0003c;0.0001)</p></sec><sec id="sec013"><title>Latitudinal and seasonal differences</title><p>Differences in serum measures between Trondheim (latitude 63&#x000b0;N) and Stavanger (latitude 58&#x000b0;N) in second and third trimester are presented in <xref ref-type="table" rid="pone.0195041.t005">Table 5</xref>. In both trimesters, lower levels of free and total 25(OH)D and higher PTH levels were seen at the northerly latitude. Seasonal variations in all 25(OH)D measures and PTH occurred in both trimesters, while DBP and 1,25(OH)<sub>2</sub>D did not show the same seasonal pattern (Figs <xref ref-type="fig" rid="pone.0195041.g002">2</xref> and <xref ref-type="fig" rid="pone.0195041.g003">3</xref>). After adjustment for education and vitD supplementation, similar results were seen. In the second and third trimester, respectively, 56 (36%) and 61 (47%) from Trondheim and 25 (40%) and 23 (51%) from Stavanger exhibited vitD insufficiency during wintertime. Of the women who were in the third trimester during the dark season, 15 (12%) from Trondheim and 3 (7%) from Stavanger had VDD.</p><fig id="pone.0195041.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.g002</object-id><label>Fig 2</label><caption><title>Seasonal variation of serum measures in second trimester.</title><p><bold>(A)</bold> Seasonal variation of serum total, free and bioavailable 25(OH)D, PTH and DBP in second trimester. <bold>(B)</bold> Seasonal variation of serum 1,25(OH)<sub>2</sub>D in second trimester, in a sub-analysis including 250 women living in Trondheim, Norway. Solid squares represent women living in Trondheim, Norway (latitude 63&#x000b0;N) and grey dots represent women living in Stavanger, Norway (latitude 58&#x000b0;N). Vertical lines represent 95% confidence intervals. A multivariable linear regression analysis was used, and separate analyses were performed for second and third trimester. In analyses involving 1,25(OH)<sub>2</sub>D, we used the pweight function in Stata to account for the sampling scheme (the inverse of the probability of an observation being selected into the sample). Abbreviations: PTH, parathyroid hormone; DBP, vitamin D-binding protein.</p></caption><graphic xlink:href="pone.0195041.g002"/></fig><fig id="pone.0195041.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.g003</object-id><label>Fig 3</label><caption><title>Seasonal variation of serum measures in third trimester.</title><p><bold>(A)</bold> Seasonal variation of serum total, free and bioavailable 25(OH)D, PTH and DBP in third trimester. <bold>(B)</bold> Seasonal variation of serum 1,25(OH)<sub>2</sub>D in third trimester, in a sub-analysis including 250 women living in Trondheim, Norway. Solid squares represent women living in Trondheim, Norway (latitude 63&#x000b0;N) and grey dots represent women living in Stavanger, Norway (latitude 58&#x000b0;N). Vertical lines represent 95% confidence intervals. A multivariable linear regression analysis was used, and separate analyses were performed for second and third trimester. In analyses involving 1,25(OH)<sub>2</sub>D, we used the pweight function in Stata to account for the sampling scheme (the inverse of the probability of an observation being selected into the sample). Abbreviations: PTH, parathyroid hormone, DBP, vitamin D-binding protein.</p></caption><graphic xlink:href="pone.0195041.g003"/></fig><table-wrap id="pone.0195041.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0195041.t005</object-id><label>Table 5</label><caption><title>Latitudinal differences between Trondheim, Norway (latitude 63&#x000b0;N) and Stavanger, Norway (latitude 58&#x000b0;N) in serum measures in second<xref ref-type="table-fn" rid="t005fn001">*</xref> and third trimester<xref ref-type="table-fn" rid="t005fn002">**</xref>.</title></caption><alternatives><graphic id="pone.0195041.t005g" xlink:href="pone.0195041.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Serum measures</th><th align="center" rowspan="1" colspan="1">Serum levels<break/>Trondheim</th><th align="center" rowspan="1" colspan="1">Serum levels<break/>Stavanger</th><th align="center" rowspan="1" colspan="1">Differences between<break/>Trondheim and Stavanger<break/>(95% CI)</th><th align="right" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t005fn003">***</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Second trimester</bold></td><td align="center" rowspan="1" colspan="1">(n = 660)<xref ref-type="table-fn" rid="t005fn004"><sup>a</sup></xref></td><td align="center" rowspan="1" colspan="1">(n = 195)</td><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">25(OH)D (nmol/L)</td><td align="center" rowspan="1" colspan="1">64.9</td><td align="center" rowspan="1" colspan="1">73.0</td><td align="center" rowspan="1" colspan="1">8.1 (4.2 to 12.0)</td><td align="right" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Calculated free 25(OH)D (pmol/L)<xref ref-type="table-fn" rid="t005fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">15.1</td><td align="center" rowspan="1" colspan="1">16.6</td><td align="center" rowspan="1" colspan="1">1.5 (0.6 to 2.4)</td><td align="right" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin-bound 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t005fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">5.03</td><td align="center" rowspan="1" colspan="1">5.43</td><td align="center" rowspan="1" colspan="1">0.40 (0.09 to 0.71)</td><td align="right" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Bioavailable 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t005fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">5.04</td><td align="center" rowspan="1" colspan="1">5.45</td><td align="center" rowspan="1" colspan="1">0.40 (0.09 to 0.72)</td><td align="right" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">PTH (pmol/L)</td><td align="center" rowspan="1" colspan="1">2.82</td><td align="center" rowspan="1" colspan="1">2.59</td><td align="center" rowspan="1" colspan="1">-0.23 (-0.41 to -0.06)</td><td align="right" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium (mmol/L)</td><td align="center" rowspan="1" colspan="1">2.270</td><td align="center" rowspan="1" colspan="1">2.263</td><td align="center" rowspan="1" colspan="1">-0.007(-0.019 to 0.004)</td><td align="right" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Corrected Calcium (mmol/L)</td><td align="center" rowspan="1" colspan="1">2.336</td><td align="center" rowspan="1" colspan="1">2.335</td><td align="center" rowspan="1" colspan="1">-0.001 (-0.011 to 0.009)</td><td align="right" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Magnesium (mmol/L)<xref ref-type="table-fn" rid="t005fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">0.751</td><td align="center" rowspan="1" colspan="1">0.736</td><td align="center" rowspan="1" colspan="1">-0.015 (-0.022 to -0.007)</td><td align="right" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphate (mmol/L)</td><td align="center" rowspan="1" colspan="1">1.199</td><td align="center" rowspan="1" colspan="1">1.185</td><td align="center" rowspan="1" colspan="1">-0.014 (-0.035 to 0.007)</td><td align="right" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/L)</td><td align="center" rowspan="1" colspan="1">36.76</td><td align="center" rowspan="1" colspan="1">36.39</td><td align="center" rowspan="1" colspan="1">-0.37 (-0.71 to -0.03)</td><td align="right" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (&#x003bc;mol/L)<xref ref-type="table-fn" rid="t005fn005"><sup>b</sup></xref></td><td align="center" rowspan="1" colspan="1">5.71</td><td align="center" rowspan="1" colspan="1">5.94</td><td align="center" rowspan="1" colspan="1">0.23 (0.09 to 0.36)</td><td align="right" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Third trimester</bold></td><td align="center" rowspan="1" colspan="1">(n = 603)</td><td align="center" rowspan="1" colspan="1">(n = 158)</td><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">61.9</td><td align="center" rowspan="1" colspan="1">70.7</td><td align="center" rowspan="1" colspan="1">8.9 (4.3 to 13.4)</td><td align="right" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Calculated free 25(OH)D (pmol/L)<xref ref-type="table-fn" rid="t005fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">13.1</td><td align="center" rowspan="1" colspan="1">14.2</td><td align="center" rowspan="1" colspan="1">1.1 (0.2 to 2.1)</td><td align="right" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin-bound 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t005fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">3.969</td><td align="center" rowspan="1" colspan="1">4.271</td><td align="center" rowspan="1" colspan="1">0.302 (-0.002 to 0.606)</td><td align="right" rowspan="1" colspan="1">0.052</td></tr><tr><td align="left" rowspan="1" colspan="1">Bioavailable 25(OH)D (nmol/L)<xref ref-type="table-fn" rid="t005fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">3.98</td><td align="center" rowspan="1" colspan="1">4.29</td><td align="center" rowspan="1" colspan="1">0.30 (-0.02 to 0.61)</td><td align="right" rowspan="1" colspan="1">0.051</td></tr><tr><td align="left" rowspan="1" colspan="1">PTH (pmol/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">3.69</td><td align="center" rowspan="1" colspan="1">3.30</td><td align="center" rowspan="1" colspan="1">-0.39 (-0.67 to -0.11)</td><td align="right" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium (mmol/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">2.245</td><td align="center" rowspan="1" colspan="1">2.251</td><td align="center" rowspan="1" colspan="1">0.006 (-0.007 to 0.019)</td><td align="right" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Corrected Calcium (mmol/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">2.368</td><td align="center" rowspan="1" colspan="1">2.381</td><td align="center" rowspan="1" colspan="1">0.013 (0.000 to 0.025)</td><td align="right" rowspan="1" colspan="1">0.046</td></tr><tr><td align="left" rowspan="1" colspan="1">Magnesium (mmol/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">0.738</td><td align="center" rowspan="1" colspan="1">0.718</td><td align="center" rowspan="1" colspan="1">-0.021 (-0.029 to -0.013)</td><td align="right" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphate (mmol/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">1.169</td><td align="center" rowspan="1" colspan="1">1.178</td><td align="center" rowspan="1" colspan="1">0.009 (-0.167 to 0.346)</td><td align="right" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/L)<xref ref-type="table-fn" rid="t005fn006"><sup>c</sup></xref></td><td align="center" rowspan="1" colspan="1">33.83</td><td align="center" rowspan="1" colspan="1">33.48</td><td align="center" rowspan="1" colspan="1">-0.35 (-0.70 to 0.00)</td><td align="right" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (&#x003bc;mol/L)<xref ref-type="table-fn" rid="t005fn007"><sup>d</sup></xref></td><td align="center" rowspan="1" colspan="1">6.42</td><td align="center" rowspan="1" colspan="1">6.76</td><td align="center" rowspan="1" colspan="1">0.34 (0.16 to 0.51)</td><td align="right" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>*The blood samples were collected between 18&#x02013;22 weeks of pregnancy.</p></fn><fn id="t005fn002"><p>**The blood samples were collected between 32&#x02013;36 weeks of pregnancy.</p></fn><fn id="t005fn003"><p>***A multivariable linear regression was used, and separate analyses were performed in second and third trimester.</p></fn><fn id="t005fn004"><p><sup>a</sup>One woman from Trondheim is missing.</p></fn><fn id="t005fn005"><p><sup>b</sup>One woman from Stavanger is missing.</p></fn><fn id="t005fn006"><p><sup>c</sup>23 women from Trondheim and 14 women from Stavanger have missing values.</p></fn><fn id="t005fn007"><p><sup>d</sup>24 women from Trondheim and 14 women from Stavanger have missing values.</p></fn><fn id="t005fn008"><p>Abbreviations: CI, confidence interval; PTH, parathyroid hormone; DBP, vitamin D-binding protein.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec014"><title>Association of vitamin D measures and PTH with pregnancy outcomes (gestational diabetes mellitus and birthweight)</title><p>In the simple linear regression analysis, lower total and free 25(OH)D levels in second trimester were associated with higher BW (change in BW for each 1-unit increase in the serum measure 25(OH)D and free 25(OH)D was -1.8, (CI -3.3 to -0.4) g and -7.7 (CI -13.8 to -1.6) g, respectively). In a multivariable regression model the association was almost fully attenuated (change in BW for each 1-unit increase in the serum measure 25(OH)D and free 25(OH)D was -0.5 (CI -2.1 to 1.1) g and -1.2 (CI -7.8 to 5.4) g, respectively). No association of 1,25(OH)<sub>2</sub>D and PTH with BW was found in the simple linear regression analysis (change in BW for each 1-unit increase in the serum measure 1,25(OH)<sub>2</sub>D and PTH was 0.5 (CI -0.9 to 1.9) g and 29.2 (CI -4.2 to 62.6) g, respectively) or in a multivariable regression model (change in BW for each 1-unit increase in the serum measure 1,25(OH)<sub>2</sub>D and PTH was -0.3 (CI -1.8 to 1.2) g and -5.2 (CI -39.9 to 29.6) g, respectively)</p><p>No associations of 25(OH)D measures, 1,25(OH)<sub>2</sub>D and PTH with GDM were observed in the logistic regression modelling (25(OH)D: crude odds ratio (OR) 1.00 (CI 0.99 to 1.01), adjusted OR 1.00 (CI 0.99 to 1.02); Free 25(OH)D: crude OR 1.00 (CI 0.95 to 1.05), adjusted OR 1.00 (CI 0.94 to 1.06); 1,25(OH)<sub>2</sub>D: crude OR 1.00 (CI 0.99 to 1.01), adjusted OR 1.00 (CI 0.99 to 1.01); PTH: crude OR 1.19 (0.92 to 1.52), adjusted OR 1.18 (CI 0.90 to 1.54)) (<xref ref-type="supplementary-material" rid="pone.0195041.s003">S3</xref> and <xref ref-type="supplementary-material" rid="pone.0195041.s004">S4</xref> Tables). The same analyses were also performed in third trimester, but no substantial differences were found. After adjustment for education and intake of vitD, calcium and fish, similar results were observed.</p></sec></sec><sec sec-type="conclusions" id="sec015"><title>Discussion</title><p>To our knowledge, this is the largest longitudinal study investigating several indices of vitD metabolism at two time points during pregnancy. In accordance with previous studies, hypovitaminosis D was frequent, and 246 (34%) of the well-educated, Caucasian women had vitD insufficiency and 52 (7%) VDD in the third trimester. In spite of Northern latitudes, the prevalence was lower than reported in most previous European studies of Caucasian pregnant women [<xref rid="pone.0195041.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0195041.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0195041.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0195041.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0195041.ref047" ref-type="bibr">47</xref>&#x02013;<xref rid="pone.0195041.ref049" ref-type="bibr">49</xref>]. In a sub-analysis (n = 250), a decline in 1.25(OH)<sub>2</sub>D was observed in half of those with VDD. This was reflected in an increased occurrence of secondary hyperparathyroidism (SHPT).</p><p>Few studies have addressed free and bioavailable 25(OH)D during pregnancy [<xref rid="pone.0195041.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0195041.ref024" ref-type="bibr">24</xref>]. We measured DBP concentrations at two time points which allowed us to calculate free and bioavailable 25(OH)D [<xref rid="pone.0195041.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0195041.ref042" ref-type="bibr">42</xref>]. Schwartz et al. observed similar measured free 25(OH)D concentrations in pregnant women and a comparator group [<xref rid="pone.0195041.ref024" ref-type="bibr">24</xref>]. A reference range for directly measured free 25(OH)D (5.3&#x02013;7.7 pg/mL &#x02248; 13.1&#x02013;19.3 pmol/L) was provided in a recent study [<xref rid="pone.0195041.ref022" ref-type="bibr">22</xref>]. The levels were in the same range in our study subjects (13.6&#x02013;15.3 pmol/L), although calculated free 25(OH)D has been claimed to overestimate the level [<xref rid="pone.0195041.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0195041.ref050" ref-type="bibr">50</xref>]. In accordance with previous studies, a rise occurred in DBP levels, which contribute to the decline in free and bioavailable 25(OH)D [<xref rid="pone.0195041.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>]. A Korean study showed lower levels of calculated bioavailable 25(OH)D in pregnant than in non-pregnant women (median 1.7 ng/mL &#x02248; 4.3 nmol/L in second and third trimester), whereas total levels were indifferent [<xref rid="pone.0195041.ref021" ref-type="bibr">21</xref>]. Median level of calculated bioavailable 25(OH)D was similar (4.4 nmol/L) in the current study. Testing of both total, free and bioavailable 25(OH)D would provide a better assessment of vitD status in conditions with changes in DBP levels like pregnancy.</p><p>Consistent with previous studies, a rise occurred in 1,25(OH)<sub>2</sub>D levels between second and third trimester [<xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>&#x02013;<xref rid="pone.0195041.ref028" ref-type="bibr">28</xref>]. We also calculated free 1,25(OH)<sub>2</sub>D levels, since the free hormone is responsible for the biological actions, and observed an increment in correspondence with total 1,25(OH)<sub>2</sub>D [<xref rid="pone.0195041.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0195041.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0195041.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0195041.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0195041.ref052" ref-type="bibr">52</xref>].</p><p>A decrease in 1,25(OH)<sub>2</sub>D levels was, however, found in 45% of those with VDD in the final trimester. These women also displayed lower 1,25(OH)<sub>2</sub>D levels in both trimesters compared to those with circulating 25(OH)D &#x0003e;75 nmol/L. Recently, Hollis et al. suggested that maximal 1,25(OH)<sub>2</sub>D concentrations during pregnancy require 25(OH)D levels of 100 nmol/L [<xref rid="pone.0195041.ref028" ref-type="bibr">28</xref>]. In the current study, only 10% of the total population reached this threshold. Most studies of 1,25(OH)<sub>2</sub>D levels in pregnancy have a small sample size, and show a large variation in third trimester (mean range 86.4&#x02013;283.0 pmol/L) [<xref rid="pone.0195041.ref018" ref-type="bibr">18</xref>]. In comparison, we observed 1,25(OH)<sub>2</sub>D concentration within the upper range (229.1 pmol/L), ranging from 105 to 408 pmol/L. The intestinal calcium absorption doubles during pregnancy, mainly attributed to the increase in 1,25(OH)<sub>2</sub>D [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0195041.ref051" ref-type="bibr">51</xref>, <xref rid="pone.0195041.ref053" ref-type="bibr">53</xref>]. The rise in 1,25(OH)<sub>2</sub>D is not driven by PTH, as a decline to the lower end of the reference level occurs [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. Thus, other regulators of 1-alpha-hydroxylase as parathyroid hormone-related protein (PTHrP), placental lactogen and estradiol must account for most of the circulating 1,25(OH)<sub>2</sub>D during pregnancy [<xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. Prolactin and placental lactogen have been proposed to compensate for the lack of vitD [<xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>]. PTHrP, which peaks late in pregnancy, could be involved in keeping serum calcium at an adequate level by mobilizing calcium from bone [<xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>]. In the current study, 4% exhibited elevated PTH levels, preferentially in months with little UVB radiation. Of these, 56% had vitD insufficiency consistent with SHPT. A similar prevalence (2%) of SHPT among Caucasian women was found in a UK study [<xref rid="pone.0195041.ref054" ref-type="bibr">54</xref>]. In the current study, PTH elevation was not seen in women with 25(OH)D levels above 74 nmol/L. This complies with Kramer et al. who reported PTH suppression at 25(OH)D levels &#x0003e;82 nmol/L during pregnancy [<xref rid="pone.0195041.ref055" ref-type="bibr">55</xref>]. The corresponding level in the non-pregnant state was 81 nmol/L [<xref rid="pone.0195041.ref055" ref-type="bibr">55</xref>]. This indicates similar thresholds for vitD supplementation in pregnancy as in the non-pregnant state. This is in line with the classification of the Endocrine Society (vitD insufficiency &#x0003c;75 nmol/L) [<xref rid="pone.0195041.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>].</p><p>The significance of the low levels of 1,25(OH)<sub>2</sub>D, as noticed in a proportion of our study subjects, is little explored. A concomitant rise in PTH and PTHrP at the end of pregnancy may pose a substantial burden on the maternal skeleton and could explain some of the cases with pregnancy-associated osteoporosis. Although 1,25(OH)<sub>2</sub>D is replaced by compensatory hormones to maintain calcium homeostasis, we postulate that this could impact the fetal and maternal skeleton adversely.</p><p>So far, the relationship between maternal 1,25(OH)<sub>2</sub>D levels and skeletal outcomes has not been addressed, while studies on 25(OH)D status and bone health in the offspring are diverging [<xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. Severe VDD in pregnancy is associated with hypocalcemia, rickets and craniotabes in the infant [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0195041.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. Observational studies show a positive association between maternal calcium intake and fetal bone development, as well as postnatal bone mineral content (BMC) and bone mineral density (BMD), while RCTs show conflicting results [<xref rid="pone.0195041.ref053" ref-type="bibr">53</xref>]. In a RCT from the UK, a daily supplementation of 25 &#x003bc;g vitD during pregnancy did not improve BMC of the infant [<xref rid="pone.0195041.ref056" ref-type="bibr">56</xref>]. However, in a subgroup born in the winter season, a significant effect on BMC was seen [<xref rid="pone.0195041.ref056" ref-type="bibr">56</xref>]. Longitudinal studies investigating association between maternal vitD status and BMC in offspring at 9-years of age show diverging results [<xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref057" ref-type="bibr">57</xref>]. In an Australian study (n = 341 mother-offspring pairs), maternal vitD inadequacy in second trimester was associated with reduced peak bone mass in the 20-year-old offspring, implying increased risk for osteoporosis in the future [<xref rid="pone.0195041.ref058" ref-type="bibr">58</xref>].</p><p>Numerous studies, including a meta-analysis have shown that VDD is associated with adverse pregnancy outcomes [<xref rid="pone.0195041.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0195041.ref007" ref-type="bibr">7</xref>]. The meta-analysis of observational studies, which included more than 22,000 women, concluded that maternal VDD is associated with an increased risk for GDM and lower birthweight infants [<xref rid="pone.0195041.ref006" ref-type="bibr">6</xref>]. A Canadian study demonstrated an association between PTH and GDM, but not 25(OH)D and 1,25(OH)<sub>2</sub>D, and pregnancy outcomes [<xref rid="pone.0195041.ref059" ref-type="bibr">59</xref>]. We found no association of vitD measures and PTH with GDM. In contrast to other studies, lower 25(OH)D was related to higher BW, but not after adjusting for potential confounding factors [<xref rid="pone.0195041.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>]. The same relationship was observed between free 25(OH)D and BW. In previous studies reporting a positive association between maternal vitD and birthweight, a higher proportion of women had VDD compared to our study [<xref rid="pone.0195041.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0195041.ref061" ref-type="bibr">61</xref>]. Hollis et al. proposed that 25(OH)D levels should be at least 100 nmol/L to give beneficial health effects and lower risk for adverse pregnancy outcomes [<xref rid="pone.0195041.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0195041.ref052" ref-type="bibr">52</xref>, <xref rid="pone.0195041.ref062" ref-type="bibr">62</xref>]. This was supported by a recent study showing that pregnant women with 25(OH)D levels &#x02265;100 nmol/L had a 62% lower risk of preterm birth compared to those with concentrations &#x0003c;50 nmol/L [<xref rid="pone.0195041.ref062" ref-type="bibr">62</xref>]. The fact that only 10% of our study participants reached levels &#x02265;100 nmol/L may have reduced our ability to detect an association. Neither 1,25(OH)<sub>2</sub>D nor PTH were associated with BW. Morley et al. reported a positive relationship between PTH and BW, whereas 25(OH)D was associated with reduced intrauterine long bone growth [<xref rid="pone.0195041.ref063" ref-type="bibr">63</xref>]. RCTs addressing the effects of vitD supplementation on pregnancy outcomes have shown diverging results [<xref rid="pone.0195041.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0195041.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0195041.ref054" ref-type="bibr">54</xref>]. This may be attributed to differences between studies, including the prevalence of VDD, calcium status, the vitD supplement dose, and start of the intervention [<xref rid="pone.0195041.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0195041.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref027" ref-type="bibr">27</xref>].</p><p>Several factors influence 25(OH)D levels including ethnicity, food and sun habits, latitude, altitude, season, and genetic polymorphisms [<xref rid="pone.0195041.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0195041.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0195041.ref030" ref-type="bibr">30</xref>]. Most previous studies show minor changes of 25(OH)D during pregnancy [<xref rid="pone.0195041.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0195041.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>]. This is in line with our findings showing a very modest decline in 25(OH)D between second and third trimester. Maternal 25(OH)D levels seem to remain relatively stable during pregnancy, despite the increased synthesis of 1,25(OH)<sub>2</sub>D and the transplacental transfer of 25(OH)D to the fetus [<xref rid="pone.0195041.ref026" ref-type="bibr">26</xref>]. Severe VDD during pregnancy was observed in a small proportion of the study subjects. This is of concern, as normal vitD levels in the neonates are reliant on adequate maternal vitD status [<xref rid="pone.0195041.ref064" ref-type="bibr">64</xref>].</p><p>Few studies have addressed vitD status in pregnant women at northern latitudes and the impact of small latitudinal differences [<xref rid="pone.0195041.ref047" ref-type="bibr">47</xref>]. Despite minor differences in latitude and similar intake of vitD, levels of total and free 25(OH)D were lower at the northerly study site in both trimesters. VitD insufficiency was less frequent in third trimester (34%) than in a Swedish study (65%), performed at the same latitude as our southern study site [<xref rid="pone.0195041.ref030" ref-type="bibr">30</xref>]. This was reflected in higher mean PTH level among the Swedish women [<xref rid="pone.0195041.ref030" ref-type="bibr">30</xref>]. The difference in prevalence may be attributed to lower vitD intake in the Swedish study.</p><p>In the dark season, UVB-mediated synthesis of vitD is absent at northern latitudes, and vitD has to be obtained through diet and supplements [<xref rid="pone.0195041.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0195041.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0195041.ref047" ref-type="bibr">47</xref>]. Western-style diet has low content of vitD, and in Norway, few foods are fortified with vitD [<xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0195041.ref065" ref-type="bibr">65</xref>]. In Norway, the authorities recommend a daily vitD supplement of 10 &#x003bc;g, a weekly intake of 300&#x02013;450 g fish, and additionally 900 mg calcium daily [<xref rid="pone.0195041.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0195041.ref066" ref-type="bibr">66</xref>]. In contrast, there are no specific Swedish supplement recommendations [<xref rid="pone.0195041.ref030" ref-type="bibr">30</xref>, <xref rid="pone.0195041.ref067" ref-type="bibr">67</xref>]. It is of concern that only 18% of the well-educated women followed the vitD supplement advices, and only half adhered to the recommendations concerning fish and calcium intake.</p><p>The major strengths of the present study are the large number of participants recruited all year round, a high follow-up rate, repeated sampling during pregnancy and standardized procedures for sampling. Analyses were performed concurrently, applying the same instruments and procedures. The study population was ethnically homogenous contributing to limited bias due to skin pigmentation, clothing habits and genetic polymorphisms [<xref rid="pone.0195041.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0195041.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0195041.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>]. Furthermore, the study sites were located in different geographical regions of Norway, providing an opportunity to investigate latitudinal differences.</p><p>The participants were well-educated Caucasian women with low-risk pregnancies, which may affect the generalizability. Serum 25(OH)D was analyzed by ECLIA (Roche), although liquid chromatography-tandem mass spectrometry (LC-MS/MS) is considered to be the golden standard [<xref rid="pone.0195041.ref017" ref-type="bibr">17</xref>]. The FFQ used in this study may overestimate the intake of vitD [<xref rid="pone.0195041.ref035" ref-type="bibr">35</xref>]. The calculation of free 25(OH)D and 1,25(OH)D are dependent on several factors, including accurate measurements of DBP and albumin [<xref rid="pone.0195041.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0195041.ref050" ref-type="bibr">50</xref>]. Nielsen et al. reported a high correlation between calculated free and directly measured 25(OH)D (r = &#x0003e;0.80), albeit calculation of free 25(OH)D levels may give an overestimation compared to direct measurement [<xref rid="pone.0195041.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0195041.ref050" ref-type="bibr">50</xref>]. In this study, several comparisons were made, thus there is an increased probability for false positive findings, and the results need to be interpreted with care.</p></sec><sec sec-type="conclusions" id="sec016"><title>Conclusions</title><p>Although Norwegian authorities recommend vitD supplementation and fish intake during pregnancy, we show that hypovitaminosis D in pregnancy is frequent in well-educated Caucasian women, particularly during wintertime. This was reflected in low adherence to the recommendations. Despite minor differences in latitude, levels of total and free 25(OH)D were lower at the northerly study sight at both second and third trimester. It is noticeable that almost half of those with 25(OH)D levels below 30 nmol/L experienced a decline in 1,25(OH)<sub>2</sub>D concentration between second and third trimester (sub-analysis). These women also displayed lower 1,25(OH)<sub>2</sub>D levels, as reflected in PTH elevation. The current findings are of concern as maternal vitD insufficiency has been shown to associate with lower offspring peak bone mass. Our data highlight the need for increased attention regarding vitD requirement during pregnancy among policy-makers, physicians and the general population. The authorities&#x02019; recommendations should be revisited, and strategies to ensure adherence should be implemented.</p></sec><sec sec-type="supplementary-material" id="sec017"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0195041.s001"><label>S1 Table</label><caption><title>The reference range, limit of detection and total analytical coefficient of variation (CV) of biochemical methods used.</title><p>*25(OH)D, PTH, total calcium, magnesium, phosphate, albumin and creatinine were analyzed at Department of Medical Biochemistry, St. Olavs hospital, Trondheim University Hospital.</p><p>**DBP and 1,25(OH)<sub>2</sub>D were analyzed at Hormone Laboratory, Oslo University Hospital. Abbreviations: CV, total analytical coefficient of variation; PTH, parathyroid hormone; ECLIA, electrochemiluminescence immunoassay; DBP, Vitamin D-binding protein; RIA, radioimmunoassay.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195041.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195041.s002"><label>S2 Table</label><caption><title>Pregnancy outcomes.</title><p>Continuous variables are given as means &#x000b1; standard deviations (SD) and categorical variables are given as numbers (<italic>n</italic>) with percentages (%).</p><p>&#x02020;Gestational hypertension was defined as systolic blood pressure &#x0003e;140 mm Hg, diastolic blood pressure &#x0003e;90 mm Hg, or both in women with no pregestational hypertension.</p><p>&#x02020;&#x02020;The criteria for gestational diabetes were fasting glucose level in whole blood &#x02265;6.1 mmol/L,or plasma glucose &#x02265;7.0 mmol/L, or 2-hour glucose level &#x02265;7.8 mmol/L after oral glucose tolerance test in women with no pregestational diabetes.</p><p>*A total of 81 women from Trondheim and 49 from Stavanger are missing.</p><p>**A total of 100 women from Trondheim and 53 women from Stavanger are missing.</p><p>***A total of 60 women from Trondheim and 10 women from Stavanger are missing.</p><p>****Two women from Trondheim and one from Stavanger are missing.</p><p>*****One woman from Trondheim and one from Stavanger are missing.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195041.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195041.s003"><label>S3 Table</label><caption><title>Association of vitamin D measures and PTH with birthweight.</title><p>Linear regression analysis was used to estimate the change of birthweight for each 1-unit increase in the serum measure.</p><p><sup>&#x02020;</sup>The blood samples were collected in second trimester (pregnancy week 18&#x02013;22).</p><p>*In this analysis, we adjusted for study site, season, age, pre-pregnancy BMI, parity and pre-pregnancy physical activity.</p><p>**In a sub-analysis of 1,25(OH)<sub>2</sub>D, 250 women from Trondheim were included. We have applied probability weights (the inverse of the probability of an observation being selected into the sample) in the statistical analysis of 1,25(OH)<sub>2</sub>D to produce estimates representative of the total Trondheim population.</p><p>Abbreviations: PTH, parathyroid hormone, CI, confidence interval; BMI, body mass index.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195041.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0195041.s004"><label>S4 Table</label><caption><title>Association of vitamin D measures and PTH with gestational diabetes mellitus.</title><p>Logistic regression analysis was used to estimate odds ratio. Odds ratio for gestational diabetes mellitus for each 1-unit increase in the serum measure.</p><p><sup>&#x02020;</sup>The blood samples were collected in second trimester (pregnancy week 18&#x02013;22).</p><p>*In this analysis, we adjusted for study site, season, age, pre-pregnancy BMI, parity and pre-pregnancy physical activity.</p><p>**In a sub-analysis of 1,25(OH)<sub>2</sub>D, 250 women from Trondheim were included. We have applied probability weights (the inverse of the probability of an observation being selected into the sample) in the statistical analysis of 1,25(OH)<sub>2</sub>D to produce estimates representative of the total Trondheim population.</p><p>Abbreviations: PTH, parathyroid hormone; OR, Odds ratio; CI, Confidence Interval; BMI, body mass index.</p><p>(DOCX)</p></caption><media xlink:href="pone.0195041.s004.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors would like to thank all the women who volunteered to participate in this research.</p></ack><ref-list><title>References</title><ref id="pone.0195041.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Hossain</surname><given-names>N</given-names></name>, <name><surname>Kanani</surname><given-names>FH</given-names></name>, <name><surname>Ramzan</surname><given-names>S</given-names></name>, <name><surname>Kausar</surname><given-names>R</given-names></name>, <name><surname>Ayaz</surname><given-names>S</given-names></name>, <name><surname>Khanani</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2014</year>;<volume>99</volume>(<issue>7</issue>):<fpage>2448</fpage>&#x02013;<lpage>55</lpage>. Epub 2014/03/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2013-3491">10.1210/jc.2013-3491</ext-link></comment> .<pub-id pub-id-type="pmid">24646102</pub-id></mixed-citation></ref><ref id="pone.0195041.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Barebring</surname><given-names>L</given-names></name>, <name><surname>Bullarbo</surname><given-names>M</given-names></name>, <name><surname>Glantz</surname><given-names>A</given-names></name>, <name><surname>Leu Agelii</surname><given-names>M</given-names></name>, <name><surname>Jagner</surname><given-names>A</given-names></name>, <name><surname>Ellis</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Preeclampsia and Blood Pressure Trajectory during Pregnancy in Relation to Vitamin D Status</article-title>. <source>PloS one</source>. <year>2016</year>;<volume>11</volume>(<issue>3</issue>):<fpage>e0152198</fpage> Epub 2016/03/31. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0152198">10.1371/journal.pone.0152198</ext-link></comment> ; PubMed Central PMCID: PMCPMC4811441.<pub-id pub-id-type="pmid">27022948</pub-id></mixed-citation></ref><ref id="pone.0195041.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Holick</surname><given-names>MF</given-names></name>, <name><surname>Binkley</surname><given-names>NC</given-names></name>, <name><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name>, <name><surname>Gordon</surname><given-names>CM</given-names></name>, <name><surname>Hanley</surname><given-names>DA</given-names></name>, <name><surname>Heaney</surname><given-names>RP</given-names></name>, <etal>et al</etal>
<article-title>Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline</article-title>. <source>The Journal of Clinical Endocrinology &#x00026; Metabolism</source>. <year>2011</year>;<volume>96</volume>(<issue>7</issue>):<fpage>1911</fpage>&#x02013;<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2011-0385">10.1210/jc.2011-0385</ext-link></comment>
<pub-id pub-id-type="pmid">21646368</pub-id></mixed-citation></ref><ref id="pone.0195041.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Dror</surname><given-names>DK</given-names></name>, <name><surname>Allen</surname><given-names>LH</given-names></name>. <article-title>Vitamin D inadequacy in pregnancy: biology, outcomes, and interventions</article-title>. <source>Nutrition Reviews</source>. <year>2014</year>;<volume>68</volume>(<issue>8</issue>):<fpage>465</fpage>&#x02013;<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1753-4887.2010.00306.x">10.1111/j.1753-4887.2010.00306.x</ext-link></comment>
<pub-id pub-id-type="pmid">20646224</pub-id></mixed-citation></ref><ref id="pone.0195041.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Palacios</surname><given-names>C</given-names></name>, <name><surname>Gonzalez</surname><given-names>L</given-names></name>. <article-title>Is vitamin D deficiency a major global public health problem?</article-title>
<source>The Journal of steroid biochemistry and molecular biology</source>. <year>2014</year>;<volume>144</volume> Pt A:<fpage>138</fpage>&#x02013;<lpage>45</lpage>. Epub 2013/11/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsbmb.2013.11.003">10.1016/j.jsbmb.2013.11.003</ext-link></comment> ; PubMed Central PMCID: PMCPMC4018438.<pub-id pub-id-type="pmid">24239505</pub-id></mixed-citation></ref><ref id="pone.0195041.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Aghajafari</surname><given-names>F</given-names></name>, <name><surname>Nagulesapillai</surname><given-names>T</given-names></name>, <name><surname>Ronksley</surname><given-names>PE</given-names></name>, <name><surname>Tough</surname><given-names>SC</given-names></name>, <name><surname>O'Beirne</surname><given-names>M</given-names></name>, <name><surname>Rabi</surname><given-names>DM</given-names></name>. <article-title>Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies</article-title>. <source>BMJ (Clinical research ed)</source>. <year>2013</year>;<volume>346</volume>:<fpage>f1169</fpage> Epub 2013/03/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.f1169">10.1136/bmj.f1169</ext-link></comment> .<pub-id pub-id-type="pmid">23533188</pub-id></mixed-citation></ref><ref id="pone.0195041.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>De-Regil</surname><given-names>LM</given-names></name>, <name><surname>Palacios</surname><given-names>C</given-names></name>, <name><surname>Lombardo</surname><given-names>LK</given-names></name>, <name><surname>Pena-Rosas</surname><given-names>JP</given-names></name>. <article-title>Vitamin D supplementation for women during pregnancy</article-title>. <source>The Cochrane database of systematic reviews</source>. <year>2016</year>;(<issue>1</issue>):<fpage>Cd008873</fpage> Epub 2016/01/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD008873.pub3">10.1002/14651858.CD008873.pub3</ext-link></comment> .<pub-id pub-id-type="pmid">26765344</pub-id></mixed-citation></ref><ref id="pone.0195041.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Moon</surname><given-names>RJ</given-names></name>, <name><surname>Harvey</surname><given-names>NC</given-names></name>, <name><surname>Cooper</surname><given-names>C</given-names></name>. <article-title>ENDOCRINOLOGY IN PREGNANCY: Influence of maternal vitamin D status on obstetric outcomes and the fetal skeleton. European journal of endocrinology /</article-title>
<source>European Federation of Endocrine Societies</source>. <year>2015</year>;<volume>173</volume>(<issue>2</issue>):<fpage>R69</fpage>&#x02013;<lpage>83</lpage>. Epub 2015/04/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1530/eje-14-0826">10.1530/eje-14-0826</ext-link></comment> ; PubMed Central PMCID: PMCPMC4968635.<pub-id pub-id-type="pmid">25862787</pub-id></mixed-citation></ref><ref id="pone.0195041.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Holmes</surname><given-names>VA</given-names></name>, <name><surname>Barnes</surname><given-names>MS</given-names></name>, <name><surname>Alexander</surname><given-names>HD</given-names></name>, <name><surname>McFaul</surname><given-names>P</given-names></name>, <name><surname>Wallace</surname><given-names>JM</given-names></name>. <article-title>Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study</article-title>. <source>The British journal of nutrition</source>. <year>2009</year>;<volume>102</volume>(<issue>6</issue>):<fpage>876</fpage>&#x02013;<lpage>81</lpage>. Epub 2009/04/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0007114509297236">10.1017/S0007114509297236</ext-link></comment> .<pub-id pub-id-type="pmid">19331703</pub-id></mixed-citation></ref><ref id="pone.0195041.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Elder</surname><given-names>CJ</given-names></name>, <name><surname>Bishop</surname><given-names>NJ</given-names></name>. <article-title>Rickets</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9929</issue>):<fpage>1665</fpage>&#x02013;<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(13)61650-5">10.1016/S0140-6736(13)61650-5</ext-link></comment> .<pub-id pub-id-type="pmid">24412049</pub-id></mixed-citation></ref><ref id="pone.0195041.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Baird</surname><given-names>J</given-names></name>, <name><surname>Jacob</surname><given-names>C</given-names></name>, <name><surname>Barker</surname><given-names>M</given-names></name>, <name><surname>Fall</surname><given-names>CHD</given-names></name>, <name><surname>Hanson</surname><given-names>M</given-names></name>, <name><surname>Harvey</surname><given-names>NC</given-names></name>, <etal>et al</etal>
<article-title>Developmental Origins of Health and Disease: A Lifecourse Approach to the Prevention of Non-Communicable Diseases</article-title>. <source>Healthcare</source>. <year>2017</year>;<volume>5</volume>(<issue>1</issue>):<fpage>14</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/healthcare5010014">10.3390/healthcare5010014</ext-link></comment> PMC5371920. <pub-id pub-id-type="pmid">28282852</pub-id></mixed-citation></ref><ref id="pone.0195041.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Gezmish</surname><given-names>O</given-names></name>, <name><surname>Black</surname><given-names>MJ</given-names></name>. <article-title>Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood</article-title>. <source>Journal of cardiovascular translational research</source>. <year>2013</year>;<volume>6</volume>(<issue>4</issue>):<fpage>588</fpage>&#x02013;<lpage>603</lpage>. Epub 2013/05/31. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12265-013-9475-y">10.1007/s12265-013-9475-y</ext-link></comment> .<pub-id pub-id-type="pmid">23719723</pub-id></mixed-citation></ref><ref id="pone.0195041.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Hart</surname><given-names>PH</given-names></name>, <name><surname>Lucas</surname><given-names>RM</given-names></name>, <name><surname>Walsh</surname><given-names>JP</given-names></name>, <name><surname>Zosky</surname><given-names>GR</given-names></name>, <name><surname>Whitehouse</surname><given-names>AJ</given-names></name>, <name><surname>Zhu</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Vitamin D in fetal development: findings from a birth cohort study</article-title>. <source>Pediatrics</source>. <year>2015</year>;<volume>135</volume>(<issue>1</issue>):<fpage>e167</fpage>&#x02013;<lpage>73</lpage>. Epub 2014/12/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1542/peds.2014-1860">10.1542/peds.2014-1860</ext-link></comment> .<pub-id pub-id-type="pmid">25511121</pub-id></mixed-citation></ref><ref id="pone.0195041.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Bouillon</surname><given-names>R</given-names></name>, <name><surname>Van Schoor</surname><given-names>NM</given-names></name>, <name><surname>Gielen</surname><given-names>E</given-names></name>, <name><surname>Boonen</surname><given-names>S</given-names></name>, <name><surname>Mathieu</surname><given-names>C</given-names></name>, <name><surname>Vanderschueren</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2013</year>;<volume>98</volume>(<issue>8</issue>):<fpage>E1283</fpage>&#x02013;<lpage>304</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2013-1195">10.1210/jc.2013-1195</ext-link></comment> .<pub-id pub-id-type="pmid">23922354</pub-id></mixed-citation></ref><ref id="pone.0195041.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Pearce</surname><given-names>SH</given-names></name>, <name><surname>Cheetham</surname><given-names>TD</given-names></name>. <article-title>Diagnosis and management of vitamin D deficiency</article-title>. <source>BMJ (Clinical research ed)</source>. <year>2010</year>;<volume>340</volume>:<fpage>b5664</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.b5664">10.1136/bmj.b5664</ext-link></comment> .<pub-id pub-id-type="pmid">20064851</pub-id></mixed-citation></ref><ref id="pone.0195041.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Lundqvist</surname><given-names>A</given-names></name>, <name><surname>Sandstr&#x000f6;m</surname><given-names>H</given-names></name>, <name><surname>Stenlund</surname><given-names>H</given-names></name>, <name><surname>Johansson</surname><given-names>I</given-names></name>, <name><surname>Hultdin</surname><given-names>J</given-names></name>. <article-title>Vitamin D Status during Pregnancy: A Longitudinal Study in Swedish Women from Early Pregnancy to Seven Months Postpartum</article-title>. <source>PloS one</source>. <year>2016</year>;<volume>11</volume>(<issue>3</issue>):<fpage>e0150385</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0150385">10.1371/journal.pone.0150385</ext-link></comment>
<pub-id pub-id-type="pmid">26938997</pub-id></mixed-citation></ref><ref id="pone.0195041.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Spiro</surname><given-names>A</given-names></name>, <name><surname>Buttriss</surname><given-names>JL</given-names></name>. <article-title>Vitamin D: An overview of vitamin D status and intake in Europe</article-title>. <source>Nutrition Bulletin / Bnf</source>. <year>2014</year>;<volume>39</volume>(<issue>4</issue>):<fpage>322</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/nbu.12108">10.1111/nbu.12108</ext-link></comment> PMC4288313. <pub-id pub-id-type="pmid">25635171</pub-id></mixed-citation></ref><ref id="pone.0195041.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Papapetrou</surname><given-names>PD</given-names></name>. <article-title>The interrelationship of serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in pregnancy at term: a meta-analysis</article-title>. <source>Hormones (Athens, Greece)</source>. <year>2010</year>;<volume>9</volume>(<issue>2</issue>):<fpage>136</fpage>&#x02013;<lpage>44</lpage>. Epub 2010/08/07. .<pub-id pub-id-type="pmid">20687397</pub-id></mixed-citation></ref><ref id="pone.0195041.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Holick</surname><given-names>MF</given-names></name>. <article-title>Vitamin D Deficiency</article-title>. <source>New England Journal of Medicine</source>. <year>2007</year>;<volume>357</volume>(<issue>3</issue>):<fpage>266</fpage>&#x02013;<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMra070553">10.1056/NEJMra070553</ext-link></comment> .<pub-id pub-id-type="pmid">17634462</pub-id></mixed-citation></ref><ref id="pone.0195041.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Hollis</surname><given-names>BW</given-names></name>, <name><surname>Wagner</surname><given-names>CL</given-names></name>. <article-title>Vitamin D supplementation during pregnancy: Improvements in birth outcomes and complications through direct genomic alteration</article-title>. <source>Mol Cell Endocrinol</source>. <year>2017</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mce.2017.01.039">10.1016/j.mce.2017.01.039</ext-link></comment> .<pub-id pub-id-type="pmid">28188842</pub-id></mixed-citation></ref><ref id="pone.0195041.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>H-J</given-names></name>, <name><surname>Ji</surname><given-names>M</given-names></name>, <name><surname>Song</surname><given-names>J</given-names></name>, <name><surname>Moon</surname><given-names>H-W</given-names></name>, <name><surname>Hur</surname><given-names>M</given-names></name>, <name><surname>Yun</surname><given-names>Y-M</given-names></name>. <article-title>Clinical Utility of Measurement of Vitamin D-Binding Protein and Calculation of Bioavailable Vitamin D in Assessment of Vitamin D Status</article-title>. <source>Annals of Laboratory Medicine</source>. <year>2017</year>;<volume>37</volume>(<issue>1</issue>):<fpage>34</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3343/alm.2017.37.1.34">10.3343/alm.2017.37.1.34</ext-link></comment> PMC5107615. <pub-id pub-id-type="pmid">27834063</pub-id></mixed-citation></ref><ref id="pone.0195041.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Aloia</surname><given-names>J</given-names></name>, <name><surname>Mikhail</surname><given-names>M</given-names></name>, <name><surname>Dhaliwal</surname><given-names>R</given-names></name>, <name><surname>Shieh</surname><given-names>A</given-names></name>, <name><surname>Usera</surname><given-names>G</given-names></name>, <name><surname>Stolberg</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Free 25(OH)D and the Vitamin D Paradox in African Americans</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2015</year>;<volume>100</volume>(<issue>9</issue>):<fpage>3356</fpage>&#x02013;<lpage>63</lpage>. Epub 2015/07/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/JC.2015-2066">10.1210/JC.2015-2066</ext-link></comment> ; PubMed Central PMCID: PMCPMC4570168.<pub-id pub-id-type="pmid">26161453</pub-id></mixed-citation></ref><ref id="pone.0195041.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>JY</given-names></name>, <name><surname>Lucey</surname><given-names>AJ</given-names></name>, <name><surname>Horgan</surname><given-names>R</given-names></name>, <name><surname>Kenny</surname><given-names>LC</given-names></name>, <name><surname>Kiely</surname><given-names>M</given-names></name>. <article-title>Impact of pregnancy on vitamin D status: a longitudinal study</article-title>. <source>The British journal of nutrition</source>. <year>2014</year>;<volume>112</volume>(<issue>7</issue>):<fpage>1081</fpage>&#x02013;<lpage>7</lpage>. Epub 2014/08/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0007114514001883">10.1017/S0007114514001883</ext-link></comment> .<pub-id pub-id-type="pmid">25159824</pub-id></mixed-citation></ref><ref id="pone.0195041.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>JB</given-names></name>, <name><surname>Lai</surname><given-names>J</given-names></name>, <name><surname>Lizaola</surname><given-names>B</given-names></name>, <name><surname>Kane</surname><given-names>L</given-names></name>, <name><surname>Markova</surname><given-names>S</given-names></name>, <name><surname>Weyland</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2014</year>;<volume>99</volume>(<issue>5</issue>):<fpage>1631</fpage>&#x02013;<lpage>7</lpage>. Epub 2014/02/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2013-3874">10.1210/jc.2013-3874</ext-link></comment> ; PubMed Central PMCID: PMCPMC4010704.<pub-id pub-id-type="pmid">24483159</pub-id></mixed-citation></ref><ref id="pone.0195041.ref025"><label>25</label><mixed-citation publication-type="book"><collab>Nordic Nutrition Recommendations 2012</collab>: <chapter-title>Integrating Nutrition and Physical Activity</chapter-title>
<edition>5th ed</edition>: <publisher-name>Nordic Council of Ministers</publisher-name>; <year>2014</year> p. <fpage>627</fpage>.</mixed-citation></ref><ref id="pone.0195041.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Kovacs</surname><given-names>CS</given-names></name>. <article-title>Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery</article-title>. <source>Physiological reviews</source>. <year>2016</year>;<volume>96</volume>(<issue>2</issue>):<fpage>449</fpage>&#x02013;<lpage>547</lpage>. Epub 2016/02/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/physrev.00027.2015">10.1152/physrev.00027.2015</ext-link></comment> .<pub-id pub-id-type="pmid">26887676</pub-id></mixed-citation></ref><ref id="pone.0195041.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Karras</surname><given-names>SN</given-names></name>, <name><surname>Fakhoury</surname><given-names>H</given-names></name>, <name><surname>Muscogiuri</surname><given-names>G</given-names></name>, <name><surname>Grant</surname><given-names>WB</given-names></name>, <name><surname>van den Ouweland</surname><given-names>JM</given-names></name>, <name><surname>Colao</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Maternal vitamin D levels during pregnancy and neonatal health: evidence to date and clinical implications</article-title>. <source>Therapeutic advances in musculoskeletal disease</source>. <year>2016</year>;<volume>8</volume>(<issue>4</issue>):<fpage>124</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1759720X16656810">10.1177/1759720X16656810</ext-link></comment> ; PubMed Central PMCID: PMCPMC4959630.<pub-id pub-id-type="pmid">27493691</pub-id></mixed-citation></ref><ref id="pone.0195041.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Hollis</surname><given-names>BW</given-names></name>, <name><surname>Johnson</surname><given-names>D</given-names></name>, <name><surname>Hulsey</surname><given-names>TC</given-names></name>, <name><surname>Ebeling</surname><given-names>M</given-names></name>, <name><surname>Wagner</surname><given-names>CL</given-names></name>. <article-title>Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness</article-title>. <source>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research</source>. <year>2011</year>;<volume>26</volume>(<issue>10</issue>):<fpage>2341</fpage>&#x02013;<lpage>57</lpage>. Epub 2011/06/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jbmr.463">10.1002/jbmr.463</ext-link></comment> ; PubMed Central PMCID: PMCPMC3183324.<pub-id pub-id-type="pmid">21706518</pub-id></mixed-citation></ref><ref id="pone.0195041.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Vandevijvere</surname><given-names>S</given-names></name>, <name><surname>Amsalkhir</surname><given-names>S</given-names></name>, <name><surname>Van Oyen</surname><given-names>H</given-names></name>, <name><surname>Moreno-Reyes</surname><given-names>R</given-names></name>. <article-title>High prevalence of vitamin D deficiency in pregnant women: a national cross-sectional survey</article-title>. <source>PloS one</source>. <year>2012</year>;<volume>7</volume>(<issue>8</issue>):<fpage>e43868</fpage> Epub 2012/09/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0043868">10.1371/journal.pone.0043868</ext-link></comment> ; PubMed Central PMCID: PMCPMC3427250.<pub-id pub-id-type="pmid">22937114</pub-id></mixed-citation></ref><ref id="pone.0195041.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Brembeck</surname><given-names>P</given-names></name>, <name><surname>Winkvist</surname><given-names>A</given-names></name>, <name><surname>Olausson</surname><given-names>H</given-names></name>. <article-title>Determinants of vitamin D status in pregnant fair-skinned women in Sweden</article-title>. <source>The British journal of nutrition</source>. <year>2013</year>;<volume>110</volume>(<issue>5</issue>):<fpage>856</fpage>&#x02013;<lpage>64</lpage>. Epub 2013/02/08. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0007114512005855">10.1017/S0007114512005855</ext-link></comment> .<pub-id pub-id-type="pmid">23388180</pub-id></mixed-citation></ref><ref id="pone.0195041.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Stafne</surname><given-names>SN</given-names></name>, <name><surname>Salvesen</surname><given-names>KA</given-names></name>, <name><surname>Romundstad</surname><given-names>PR</given-names></name>, <name><surname>Eggebo</surname><given-names>TM</given-names></name>, <name><surname>Carlsen</surname><given-names>SM</given-names></name>, <name><surname>Morkved</surname><given-names>S</given-names></name>. <article-title>Regular exercise during pregnancy to prevent gestational diabetes: a randomized controlled trial</article-title>. <source>Obstetrics and gynecology</source>. <year>2012</year>;<volume>119</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02013;<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/AOG.0b013e3182393f86">10.1097/AOG.0b013e3182393f86</ext-link></comment> .<pub-id pub-id-type="pmid">22183208</pub-id></mixed-citation></ref><ref id="pone.0195041.ref032"><label>32</label><mixed-citation publication-type="book"><collab>Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium</collab>. <chapter-title>The National Academies Collection: Reports funded by National Institutes of Health</chapter-title> In: <name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Taylor</surname><given-names>CL</given-names></name>, <name><surname>Yaktine</surname><given-names>AL</given-names></name>, <name><surname>Del Valle</surname><given-names>HB</given-names></name>, editors. <source>Dietary Reference Intakes for Calcium and Vitamin D</source>. <publisher-loc>Washington (DC)</publisher-loc>: <publisher-name>National Academies Press (US) National Academy of Sciences</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="pone.0195041.ref033"><label>33</label><mixed-citation publication-type="book"><name><surname>Kothari</surname><given-names>P</given-names></name>. <source>Data Analysis with Stata</source>: <publisher-name>Packt Publishing</publisher-name>; <year>2015</year>.</mixed-citation></ref><ref id="pone.0195041.ref034"><label>34</label><mixed-citation publication-type="book"><name><surname>Hamilton</surname><given-names>LC</given-names></name>. <source>Statistics with STATA: Version 12</source>: <publisher-name>Cengage Learning</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="pone.0195041.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>LF</given-names></name>, <name><surname>Solvoll</surname><given-names>K</given-names></name>, <name><surname>Johansson</surname><given-names>LR</given-names></name>, <name><surname>Salminen</surname><given-names>I</given-names></name>, <name><surname>Aro</surname><given-names>A</given-names></name>, <name><surname>Drevon</surname><given-names>CA</given-names></name>. <article-title>Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum</article-title>. <source>American journal of epidemiology</source>. <year>1999</year>;<volume>150</volume>(<issue>1</issue>):<fpage>75</fpage>&#x02013;<lpage>87</lpage>. Epub 1999/07/10. .<pub-id pub-id-type="pmid">10400557</pub-id></mixed-citation></ref><ref id="pone.0195041.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Andersen</surname><given-names>LF</given-names></name>, <name><surname>Veierod</surname><given-names>MB</given-names></name>, <name><surname>Johansson</surname><given-names>L</given-names></name>, <name><surname>Sakhi</surname><given-names>A</given-names></name>, <name><surname>Solvoll</surname><given-names>K</given-names></name>, <name><surname>Drevon</surname><given-names>CA</given-names></name>. <article-title>Evaluation of three dietary assessment methods and serum biomarkers as measures of fruit and vegetable intake, using the method of triads</article-title>. <source>The British journal of nutrition</source>. <year>2005</year>;<volume>93</volume>(<issue>4</issue>):<fpage>519</fpage>&#x02013;<lpage>27</lpage>. Epub 2005/06/11. .<pub-id pub-id-type="pmid">15946415</pub-id></mixed-citation></ref><ref id="pone.0195041.ref037"><label>37</label><mixed-citation publication-type="book"><name><surname>Johansson</surname><given-names>L</given-names></name>, <name><surname>Solvoll</surname><given-names>K</given-names></name>. <chapter-title>Norkost 1997&#x02014;National dietary survey among men and women at age 16&#x02013;79 years</chapter-title>
<publisher-name>Norwegian State Council for Nutrition and Physical Activity</publisher-name>, <publisher-loc>Oslo[In Norwegian]</publisher-loc>
<year>1999</year>;Rapport nr. 2/1999 84.</mixed-citation></ref><ref id="pone.0195041.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Minisola</surname><given-names>S</given-names></name>, <name><surname>Pepe</surname><given-names>J</given-names></name>, <name><surname>Piemonte</surname><given-names>S</given-names></name>, <name><surname>Cipriani</surname><given-names>C</given-names></name>. <article-title>The diagnosis and management of hypercalcaemia</article-title>. <source>Bmj-Brit Med J</source>. <year>2015</year>;<fpage>350</fpage> ARTN h2723 <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.h2723">10.1136/bmj.h2723</ext-link></comment> WOS:000355918900009. <pub-id pub-id-type="pmid">26037642</pub-id></mixed-citation></ref><ref id="pone.0195041.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Sollid</surname><given-names>ST</given-names></name>, <name><surname>Hutchinson</surname><given-names>MY</given-names></name>, <name><surname>Berg</surname><given-names>V</given-names></name>, <name><surname>Fuskevag</surname><given-names>OM</given-names></name>, <name><surname>Figenschau</surname><given-names>Y</given-names></name>, <name><surname>Thorsby</surname><given-names>PM</given-names></name>, <etal>et al</etal>
<article-title>Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D</article-title>. <source>European journal of endocrinology / European Federation of Endocrine Societies</source>. <year>2016</year>;<volume>174</volume>(<issue>4</issue>):<fpage>445</fpage>&#x02013;<lpage>52</lpage>. Epub 2016/01/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1530/eje-15-1089">10.1530/eje-15-1089</ext-link></comment> ; PubMed Central PMCID: PMCPMC4763092.<pub-id pub-id-type="pmid">26733479</pub-id></mixed-citation></ref><ref id="pone.0195041.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Herrmann</surname><given-names>M</given-names></name>, <name><surname>Farrell</surname><given-names>CL</given-names></name>, <name><surname>Pusceddu</surname><given-names>I</given-names></name>, <name><surname>Fabregat-Cabello</surname><given-names>N</given-names></name>, <name><surname>Cavalier</surname><given-names>E</given-names></name>. <article-title>Assessment of vitamin D status&#x02014;a changing landscape</article-title>. <source>Clin Chem Lab Med</source>. <year>2017</year>;<volume>55</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>26</lpage>. Epub 2016/07/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1515/cclm-2016-0264">10.1515/cclm-2016-0264</ext-link></comment> .<pub-id pub-id-type="pmid">27362963</pub-id></mixed-citation></ref><ref id="pone.0195041.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Bikle</surname><given-names>DD</given-names></name>, <name><surname>Gee</surname><given-names>E</given-names></name>, <name><surname>Halloran</surname><given-names>B</given-names></name>, <name><surname>Kowalski</surname><given-names>MA</given-names></name>, <name><surname>Ryzen</surname><given-names>E</given-names></name>, <name><surname>Haddad</surname><given-names>JG</given-names></name>. <article-title>Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>1986</year>;<volume>63</volume>(<issue>4</issue>):<fpage>954</fpage>&#x02013;<lpage>9</lpage>. Epub 1986/10/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jcem-63-4-954">10.1210/jcem-63-4-954</ext-link></comment> .<pub-id pub-id-type="pmid">3745408</pub-id></mixed-citation></ref><ref id="pone.0195041.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Powe</surname><given-names>CE</given-names></name>, <name><surname>Ricciardi</surname><given-names>C</given-names></name>, <name><surname>Berg</surname><given-names>AH</given-names></name>, <name><surname>Erdenesanaa</surname><given-names>D</given-names></name>, <name><surname>Collerone</surname><given-names>G</given-names></name>, <name><surname>Ankers</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. Journal of bone and mineral research: the official journal of the</article-title>
<source>American Society for Bone and Mineral Research</source>. <year>2011</year>;<volume>26</volume>(<issue>7</issue>):<fpage>1609</fpage>&#x02013;<lpage>16</lpage>. Epub 2011/03/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jbmr.387">10.1002/jbmr.387</ext-link></comment> ; PubMed Central PMCID: PMCPMC3351032.<pub-id pub-id-type="pmid">21416506</pub-id></mixed-citation></ref><ref id="pone.0195041.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Vermeulen</surname><given-names>A</given-names></name>, <name><surname>Verdonck</surname><given-names>L</given-names></name>, <name><surname>Kaufman</surname><given-names>JM</given-names></name>. <article-title>A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum</article-title>. <source>The Journal of Clinical Endocrinology &#x00026; Metabolism</source>. <year>1999</year>;<volume>84</volume>(<issue>10</issue>):<fpage>3666</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jcem.84.10.6079">10.1210/jcem.84.10.6079</ext-link></comment> .<pub-id pub-id-type="pmid">10523012</pub-id></mixed-citation></ref><ref id="pone.0195041.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Bikle</surname><given-names>D</given-names></name>, <name><surname>Bouillon</surname><given-names>R</given-names></name>, <name><surname>Thadhani</surname><given-names>R</given-names></name>, <name><surname>Schoenmakers</surname><given-names>I</given-names></name>. <article-title>Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status?</article-title>
<source>The Journal of steroid biochemistry and molecular biology</source>. <year>2017</year> Epub 2017/01/18. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsbmb.2017.01.007">10.1016/j.jsbmb.2017.01.007</ext-link></comment> .<pub-id pub-id-type="pmid">28093353</pub-id></mixed-citation></ref><ref id="pone.0195041.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Gunasekara</surname><given-names>FI</given-names></name>, <name><surname>Richardson</surname><given-names>K</given-names></name>, <name><surname>Carter</surname><given-names>K</given-names></name>, <name><surname>Blakely</surname><given-names>T</given-names></name>. <article-title>Fixed effects analysis of repeated measures data</article-title>. <source>International journal of epidemiology</source>. <year>2014</year>;<volume>43</volume>(<issue>1</issue>):<fpage>264</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ije/dyt221">10.1093/ije/dyt221</ext-link></comment> WOS:000332341300037. <pub-id pub-id-type="pmid">24366487</pub-id></mixed-citation></ref><ref id="pone.0195041.ref046"><label>46</label><mixed-citation publication-type="book"><collab>WHO</collab>. <chapter-title>Obesity: preventing and managing the global epidemic. Report of a WHO consultation</chapter-title>
<publisher-name>World Health Organization technical report series</publisher-name>
<year>2000</year>;<volume>894</volume>:<fpage>i</fpage>&#x02013;<lpage>xii</lpage>, 1&#x02013;253. Epub 2001/03/10. .<pub-id pub-id-type="pmid">11234459</pub-id></mixed-citation></ref><ref id="pone.0195041.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Haggarty</surname><given-names>P</given-names></name>, <name><surname>Campbell</surname><given-names>DM</given-names></name>, <name><surname>Knox</surname><given-names>S</given-names></name>, <name><surname>Horgan</surname><given-names>GW</given-names></name>, <name><surname>Hoad</surname><given-names>G</given-names></name>, <name><surname>Boulton</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Vitamin D in pregnancy at high latitude in Scotland</article-title>. <source>The British journal of nutrition</source>. <year>2013</year>;<volume>109</volume>(<issue>5</issue>):<fpage>898</fpage>&#x02013;<lpage>905</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0007114512002255">10.1017/S0007114512002255</ext-link></comment> .<pub-id pub-id-type="pmid">23168244</pub-id></mixed-citation></ref><ref id="pone.0195041.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Leffelaar</surname><given-names>ER</given-names></name>, <name><surname>Vrijkotte</surname><given-names>TGM</given-names></name>, <name><surname>van Eijsden</surname><given-names>M</given-names></name>. <article-title>Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multi-ethnic Amsterdam Born Children and their Development cohort</article-title>. <source>British Journal of Nutrition</source>. <year>2010</year>;<volume>104</volume>(<issue>1</issue>):<fpage>108</fpage>&#x02013;<lpage>17</lpage>. WOS:000279748400015. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S000711451000022X">10.1017/S000711451000022X</ext-link></comment>
<pub-id pub-id-type="pmid">20193097</pub-id></mixed-citation></ref><ref id="pone.0195041.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Javaid</surname><given-names>MK</given-names></name>, <name><surname>Crozier</surname><given-names>SR</given-names></name>, <name><surname>Harvey</surname><given-names>NC</given-names></name>, <name><surname>Gale</surname><given-names>CR</given-names></name>, <name><surname>Dennison</surname><given-names>EM</given-names></name>, <name><surname>Boucher</surname><given-names>BJ</given-names></name>. <article-title>Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study</article-title>. <source>Lancet</source>. <year>2006</year>;<fpage>367</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0140-6736(06)67922-1">10.1016/s0140-6736(06)67922-1</ext-link></comment></mixed-citation></ref><ref id="pone.0195041.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Bouillon</surname><given-names>R</given-names></name>. <article-title>Free or Total 25OHD as Marker for Vitamin D Status?</article-title>
<source>Journal of Bone and Mineral Research</source>. <year>2016</year>;<volume>31</volume>(<issue>6</issue>):<fpage>1124</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jbmr.2871">10.1002/jbmr.2871</ext-link></comment> WOS:000377269200002. <pub-id pub-id-type="pmid">27172227</pub-id></mixed-citation></ref><ref id="pone.0195041.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Verhaeghe</surname><given-names>J</given-names></name>, <name><surname>Bouillon</surname><given-names>R</given-names></name>. <article-title>Calciotropic hormones during reproduction</article-title>. <source>The Journal of steroid biochemistry and molecular biology</source>. <year>1992</year>;<volume>41</volume>(<issue>3&#x02013;8</issue>):<fpage>469</fpage>&#x02013;<lpage>77</lpage>. Epub 1992/03/01. .<pub-id pub-id-type="pmid">1562518</pub-id></mixed-citation></ref><ref id="pone.0195041.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Hollis</surname><given-names>BW</given-names></name>, <name><surname>Wagner</surname><given-names>CL</given-names></name>. <article-title>New insights into the vitamin D requirements during pregnancy</article-title>. <source>Bone Res</source>. <year>2017</year>;<volume>5</volume>:<fpage>17030</fpage> Medline:28868163. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/boneres.2017.30">10.1038/boneres.2017.30</ext-link></comment>
<pub-id pub-id-type="pmid">28868163</pub-id></mixed-citation></ref><ref id="pone.0195041.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Hacker</surname><given-names>AN</given-names></name>, <name><surname>Fung</surname><given-names>EB</given-names></name>, <name><surname>King</surname><given-names>JC</given-names></name>. <article-title>Role of calcium during pregnancy: maternal and fetal needs</article-title>. <source>Nutr Rev</source>. <year>2012</year>;<volume>70</volume>(<issue>7</issue>):<fpage>397</fpage>&#x02013;<lpage>409</lpage>. Epub 2012/07/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1753-4887.2012.00491.x">10.1111/j.1753-4887.2012.00491.x</ext-link></comment> .<pub-id pub-id-type="pmid">22747842</pub-id></mixed-citation></ref><ref id="pone.0195041.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>CKH</given-names></name>, <name><surname>Sykes</surname><given-names>L</given-names></name>, <name><surname>Sethi</surname><given-names>M</given-names></name>, <name><surname>Teoh</surname><given-names>TG</given-names></name>, <name><surname>Robinson</surname><given-names>S</given-names></name>. <article-title>Vitamin D deficiency and supplementation during pregnancy</article-title>. <source>Clin Endocrinol</source>. <year>2009</year>;<volume>70</volume>(<issue>5</issue>):<fpage>685</fpage>&#x02013;<lpage>90</lpage>. WOS:000264563800005.</mixed-citation></ref><ref id="pone.0195041.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Kramer</surname><given-names>CK</given-names></name>, <name><surname>Ye</surname><given-names>C</given-names></name>, <name><surname>Hanley</surname><given-names>AJ</given-names></name>, <name><surname>Connelly</surname><given-names>PW</given-names></name>, <name><surname>Sermer</surname><given-names>M</given-names></name>, <name><surname>Zinman</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>The Relationship Between Parathyroid Hormone and 25-Hydroxyvitamin D During and After Pregnancy</article-title>. <source>The Journal of Clinical Endocrinology &#x00026; Metabolism</source>. <year>2016</year>;<volume>101</volume>(<issue>4</issue>):<fpage>1729</fpage>&#x02013;<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2015-4060">10.1210/jc.2015-4060</ext-link></comment>
<pub-id pub-id-type="pmid">26895390</pub-id></mixed-citation></ref><ref id="pone.0195041.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Cooper</surname><given-names>C</given-names></name>, <name><surname>Harvey</surname><given-names>NC</given-names></name>, <name><surname>Bishop</surname><given-names>NJ</given-names></name>, <name><surname>Kennedy</surname><given-names>S</given-names></name>, <name><surname>Papageorghiou</surname><given-names>AT</given-names></name>, <name><surname>Schoenmakers</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial</article-title>. <source>The lancet Diabetes &#x00026; endocrinology</source>. <year>2016</year>;<volume>4</volume>(<issue>5</issue>):<fpage>393</fpage>&#x02013;<lpage>402</lpage>. Epub 2016/03/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s2213-8587(16)00044-9">10.1016/s2213-8587(16)00044-9</ext-link></comment> ; PubMed Central PMCID: PMCPMC4843969.<pub-id pub-id-type="pmid">26944421</pub-id></mixed-citation></ref><ref id="pone.0195041.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Lawlor</surname><given-names>DA</given-names></name>, <name><surname>Wills</surname><given-names>AK</given-names></name>, <name><surname>Fraser</surname><given-names>A</given-names></name>, <name><surname>Sayers</surname><given-names>A</given-names></name>, <name><surname>Fraser</surname><given-names>WD</given-names></name>, <name><surname>Tobias</surname><given-names>JH</given-names></name>. <article-title>Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study (vol 381, pg 2176, 2013)</article-title>. <source>Lancet</source>. <year>2013</year>;<volume>382</volume>(<issue>9893</issue>):<fpage>684</fpage>&#x02013;. WOS:000323542400025.<pub-id pub-id-type="pmid">23972812</pub-id></mixed-citation></ref><ref id="pone.0195041.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>K</given-names></name>, <name><surname>Whitehouse</surname><given-names>AJ</given-names></name>, <name><surname>Hart</surname><given-names>PH</given-names></name>, <name><surname>Kusel</surname><given-names>M</given-names></name>, <name><surname>Mountain</surname><given-names>J</given-names></name>, <name><surname>Lye</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study</article-title>. <source>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research</source>. <year>2014</year>;<volume>29</volume>(<issue>5</issue>):<fpage>1088</fpage>&#x02013;<lpage>95</lpage>. Epub 2013/11/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jbmr.2138">10.1002/jbmr.2138</ext-link></comment> .<pub-id pub-id-type="pmid">24189972</pub-id></mixed-citation></ref><ref id="pone.0195041.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Kramer</surname><given-names>CK</given-names></name>, <name><surname>Swaminathan</surname><given-names>B</given-names></name>, <name><surname>Hanley</surname><given-names>AJ</given-names></name>, <name><surname>Connelly</surname><given-names>PW</given-names></name>, <name><surname>Sermer</surname><given-names>M</given-names></name>, <name><surname>Zinman</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Vitamin D and Parathyroid Hormone Status in Pregnancy: Effect on Insulin Sensitivity, &#x003b2;-cell Function, and Gestational Diabetes Mellitus</article-title>. <source>The Journal of Clinical Endocrinology &#x00026; Metabolism</source>. <year>2014</year>;<volume>99</volume>(<issue>12</issue>):<fpage>4506</fpage>&#x02013;<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2014-2341">10.1210/jc.2014-2341</ext-link></comment>
<pub-id pub-id-type="pmid">25202819</pub-id></mixed-citation></ref><ref id="pone.0195041.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Harvey</surname><given-names>NC</given-names></name>, <name><surname>Holroyd</surname><given-names>C</given-names></name>, <name><surname>Ntani</surname><given-names>G</given-names></name>, <name><surname>Javaid</surname><given-names>K</given-names></name>, <name><surname>Cooper</surname><given-names>P</given-names></name>, <name><surname>Moon</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Vitamin D supplementation in pregnancy: a systematic review. Health technology assessment (Winchester, England)</article-title>. <year>2014</year>;<volume>18</volume>(<issue>45</issue>):<fpage>1</fpage>&#x02013;<lpage>190</lpage>. Epub 2014/07/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3310/hta18450">10.3310/hta18450</ext-link></comment> ; PubMed Central PMCID: PMCPMC4124722.<pub-id pub-id-type="pmid">25025896</pub-id></mixed-citation></ref><ref id="pone.0195041.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Gernand</surname><given-names>AD</given-names></name>, <name><surname>Simhan</surname><given-names>HN</given-names></name>, <name><surname>Klebanoff</surname><given-names>MA</given-names></name>, <name><surname>Bodnar</surname><given-names>LM</given-names></name>. <article-title>Maternal Serum 25-Hydroxyvitamin D and Measures of Newborn and Placental Weight in a U.S. Multicenter Cohort Study</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2013</year>;<volume>98</volume>(<issue>1</issue>):<fpage>398</fpage>&#x02013;<lpage>404</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2012-3275">10.1210/jc.2012-3275</ext-link></comment> PMC3537090. <pub-id pub-id-type="pmid">23162094</pub-id></mixed-citation></ref><ref id="pone.0195041.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>McDonnell</surname><given-names>SL</given-names></name>, <name><surname>Baggerly</surname><given-names>KA</given-names></name>, <name><surname>Baggerly</surname><given-names>CA</given-names></name>, <name><surname>Aliano</surname><given-names>JL</given-names></name>, <name><surname>French</surname><given-names>CB</given-names></name>, <name><surname>Baggerly</surname><given-names>LL</given-names></name>, <etal>et al</etal>
<article-title>Maternal 25(OH)D concentrations &#x0003e;/ = 40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center</article-title>. <source>PloS one</source>. <year>2017</year>;<volume>12</volume>(<issue>7</issue>):<fpage>e0180483</fpage> Epub 2017/07/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0180483">10.1371/journal.pone.0180483</ext-link></comment> ; PubMed Central PMCID: PMCPMC5524288.<pub-id pub-id-type="pmid">28738090</pub-id></mixed-citation></ref><ref id="pone.0195041.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Morley</surname><given-names>R</given-names></name>, <name><surname>Carlin</surname><given-names>JB</given-names></name>, <name><surname>Pasco</surname><given-names>JA</given-names></name>, <name><surname>Wark</surname><given-names>JD</given-names></name>. <article-title>Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size</article-title>. <source>The Journal of clinical endocrinology and metabolism</source>. <year>2006</year>;<volume>91</volume>(<issue>3</issue>):<fpage>906</fpage>&#x02013;<lpage>12</lpage>. Epub 2005/12/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2005-1479">10.1210/jc.2005-1479</ext-link></comment> .<pub-id pub-id-type="pmid">16352684</pub-id></mixed-citation></ref><ref id="pone.0195041.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Kovacs</surname><given-names>CS</given-names></name>. <article-title>Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies</article-title>. <source>Am J Clin Nutr</source>. <year>2008</year>;<volume>88</volume>(<issue>2</issue>):<fpage>520S</fpage>&#x02013;<lpage>8S</lpage>. Epub 2008/08/12. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/ajcn/88.2.520S">10.1093/ajcn/88.2.520S</ext-link></comment> .<pub-id pub-id-type="pmid">18689394</pub-id></mixed-citation></ref><ref id="pone.0195041.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Awad</surname><given-names>AB</given-names></name>, <name><surname>Alappat</surname><given-names>L</given-names></name>, <name><surname>Valerio</surname><given-names>M</given-names></name>. <article-title>Vitamin d and metabolic syndrome risk factors: evidence and mechanisms</article-title>. <source>Critical reviews in food science and nutrition</source>. <year>2012</year>;<volume>52</volume>(<issue>2</issue>):<fpage>103</fpage>&#x02013;<lpage>12</lpage>. Epub 2011/11/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/10408391003785458">10.1080/10408391003785458</ext-link></comment> .<pub-id pub-id-type="pmid">22059957</pub-id></mixed-citation></ref><ref id="pone.0195041.ref066"><label>66</label><mixed-citation publication-type="other">Helsedirektoratet. Kosthold for gravide Graviditet, f&#x000f8;dsel og barsel: Norwegian Directorate of Health [updated 2017, May 3]. Available from: <ext-link ext-link-type="uri" xlink:href="https://helsedirektoratet.no/folkehelse/graviditet-fodsel-og-barsel/graviditet-og-svangerskap/kosthold-for-gravide">https://helsedirektoratet.no/folkehelse/graviditet-fodsel-og-barsel/graviditet-og-svangerskap/kosthold-for-gravide</ext-link>.</mixed-citation></ref><ref id="pone.0195041.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Karlsson</surname><given-names>T</given-names></name>, <name><surname>Andersson</surname><given-names>L</given-names></name>, <name><surname>Hussain</surname><given-names>A</given-names></name>, <name><surname>Bosaeus</surname><given-names>M</given-names></name>, <name><surname>Jansson</surname><given-names>N</given-names></name>, <name><surname>Osmancevic</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Lower vitamin D status in obese compared with normal-weight women despite higher vitamin D intake in early pregnancy</article-title>. <source>Clinical Nutrition</source>. <year>2015</year>;<volume>34</volume>(<issue>5</issue>):<fpage>892</fpage>&#x02013;<lpage>8</lpage>. WOS:000360949800015. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clnu.2014.09.012">10.1016/j.clnu.2014.09.012</ext-link></comment>
<pub-id pub-id-type="pmid">25307530</pub-id></mixed-citation></ref></ref-list></back></article>